Synergistic	O
transcriptional	O
activation	O
of	O
human	B-DNA
Acyl-coenzyme	I-DNA
A	I-DNA
:	I-DNA
cholesterol	I-DNA
acyltransterase-1	I-DNA
gene	I-DNA
by	O
interferon-gamma	B-protein
and	O
all-trans-retinoic	O
acid	O
THP-1	B-cell_type
cells	I-cell_type
.	O

Acyl-coenzyme	B-protein
A	I-protein
:	I-protein
cholesterol	I-protein
acyltransferase	I-protein
(	O
ACAT	B-protein
)	O
is	O
an	O
intracellular	B-protein
enzyme	I-protein
involved	O
in	O
cellular	O
cholesterol	O
homeostasis	O
and	O
in	O
atherosclerotic	O
foam	O
cell	O
formation	O
.	O

Human	B-DNA
ACAT-1	I-DNA
gene	I-DNA
contains	O
two	O
promoters	B-DNA
(	O
P1	B-DNA
and	O
P7	B-DNA
)	O
,	O
each	O
located	O
in	O
a	O
different	O
chromosome	B-DNA
(	I-DNA
1	I-DNA
and	I-DNA
7	I-DNA
)	I-DNA
(	O
Li	O
,	O
B.	O
L.	O
,	O
Li	O
,	O
X.	O
L.	O
,	O
Duan	O
,	O
Z.	O
J.	O
,	O
Lee	O
,	O
O.	O
,	O
Lin	O
,	O
S.	O
,	O
Ma	O
,	O
Z.	O
M.	O
,	O
Chang	O
,	O
C.	O
C.	O
,	O
Yang	O
,	O
X.	O
Y.	O
,	O
Park	O
,	O
J.	O
P.	O
,	O
Mohandas	O
,	O
T.	O
K.	O
,	O
Noll	O
,	O
W.	O
,	O
Chan	O
,	O
L.	O
,	O
and	O
Chang	O
,	O
T.	O
Y.	O
(	O
1999	O
)	O
J.	O
Biol	O
Chem.	O
274	O
,	O
11060-11071	O
)	O
.	O

Interferon-gamma	B-protein
(	O
IFN-gamma	B-protein
)	O
,	O
a	O
cytokine	B-protein
that	O
exerts	O
many	O
pro-atherosclerotic	O
effects	O
in	O
vivo	O
,	O
causes	O
up-regulation	O
of	O
ACAT-1	B-RNA
mRNA	I-RNA
in	O
human	B-cell_type
blood	I-cell_type
monocyte-derived	I-cell_type
macrophages	I-cell_type
and	O
macrophage-like	B-cell_type
cells	I-cell_type
but	O
not	O
in	O
other	O
cell	O
types	O
.	O

To	O
examine	O
the	O
molecular	O
nature	O
of	O
this	O
observation	O
,	O
we	O
identified	O
within	O
the	O
ACAT-1	B-DNA
P1	I-DNA
promoter	I-DNA
a	O
159-base	B-DNA
pair	I-DNA
core	I-DNA
region	I-DNA
.	O

This	O
region	O
contains	O
4	O
Sp1	B-DNA
elements	I-DNA
and	O
an	O
IFN-gamma	B-DNA
activated	I-DNA
sequence	I-DNA
(	O
GAS	B-DNA
)	O
that	O
overlaps	O
with	O
the	O
second	O
Sp1	B-DNA
element	I-DNA
.	O

In	O
the	O
monocytic	B-cell_type
cell	I-cell_type
line	I-cell_type
THP-1	I-cell_type
cell	I-cell_type
,	O
the	O
combination	O
of	O
IFN-gamma	B-protein
and	O
all-trans-retinoic	O
acid	O
(	O
a	O
known	O
differentiation	O
agent	O
)	O
enhances	O
the	O
ACAT-1	B-DNA
P1	I-DNA
promoter	I-DNA
but	O
not	O
the	O
P7	B-DNA
promoter	I-DNA
.	O

Additional	O
experiments	O
showed	O
that	O
all-trans-retinoic	O
acid	O
causes	O
large	O
induction	O
of	O
the	O
transcription	B-protein
factor	I-protein
STAT1	I-protein
,	O
while	O
IFN-gamma	B-protein
causes	O
activation	O
of	O
STAT1	B-protein
such	O
that	O
it	O
binds	O
to	O
the	O
GAS/Sp1	B-DNA
site	I-DNA
in	O
the	O
ACAT-1	B-DNA
P1	I-DNA
promoter	I-DNA
.	O

Our	O
work	O
provides	O
a	O
molecular	O
mechanism	O
to	O
account	O
for	O
the	O
effect	O
of	O
IFN-gamma	B-protein
in	O
causing	O
transcriptional	O
activation	O
of	O
ACAT-1	B-protein
in	O
macrophage-like	B-cell_type
cells	I-cell_type
.	O

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

276	NULL
,	NULL
No	NULL
.	NULL

24	NULL
,	NULL
Issue	NULL
of	NULL
June	NULL
15	NULL
,	NULL
pp	NULL
.	NULL

20989-20998	NULL
,	NULL
2001	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Synergistic	NULL
Transcriptional	NULL
Activation	NULL
of	NULL
Human	NULL
Acyl-coenzyme	NULL
A	NULL
:	NULL
Cholesterol	NULL
Acyltransterase-1	NULL
Gene	NULL
by	NULL
Interferon-y	NULL
and	NULL
All-trans-	NULL
Retinoic	NULL
Acid	NULL
THP-1	NULL
Cells*®	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
December	NULL
20	NULL
,	NULL
2000	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
February	NULL
23	NULL
,	NULL
2001	NULL
Published	NULL
,	NULL
JBC	NULL
Papers	NULL
in	NULL
Press	NULL
,	NULL
February	NULL
28	NULL
,	NULL
2001	NULL
,	NULL
DOI	NULL
10.1074/jbc.MO11488200	NULL
Jin-Bo	NULL
Zhi-Jun	NULL
Duan	NULL
}	NULL
,	NULL
Wei	NULL
Yaot	NULL
,	NULL
Oneil	NULL
Lee	NULL
``	NULL
,	NULL
Li	NULL
Yangt	NULL
,	NULL
Xin-Ying	NULL
Yangt	NULL
,	NULL
Xia	NULL
Sunt	NULL
,	NULL
Catherine	NULL
C.	NULL
Y.	NULL
Chang§	NULL
,	NULL
Ta-Yuan	NULL
Chang§1	NULL
,	NULL
and	NULL
Bo-Liang	NULL
Lit	NULL
]	NULL
From	NULL
the	NULL
{	NULL
Institute	NULL
of	NULL
Biochemistry	NULL
and	NULL
Cell	NULL
Biology	NULL
,	NULL
Shanghai	NULL
Institutes	NULL
for	NULL
Biological	NULL
Sciences	NULL
,	NULL
Chinese	NULL
Academy	NULL
of	NULL
Sciences	NULL
,	NULL
Shanghai	NULL
200031	NULL
,	NULL
China	NULL
and	NULL
the	NULL
§Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
Dartmouth	NULL
Medical	NULL
School	NULL
,	NULL
Hanover	NULL
,	NULL
New	NULL
Hampshire	NULL
03755	NULL
Acyl-coenzyme	NULL
A	NULL
:	NULL
cholesterol	NULL
acyltransferase	NULL
(	NULL
ACAT	NULL
)	NULL
is	NULL
an	NULL
intracellular	NULL
enzyme	NULL
involved	NULL
in	NULL
cellular	NULL
cholesterol	NULL
homeostasis	NULL
and	NULL
in	NULL
atherosclerotic	NULL
foam	NULL
cell	NULL
formation	NULL
.	NULL

Human	NULL
ACAT-1	NULL
gene	NULL
contains	NULL
two	NULL
promoters	NULL
(	NULL
P1	NULL
and	NULL
P7	NULL
)	NULL
,	NULL
each	NULL
located	NULL
in	NULL
a	NULL
different	NULL
chromosome	NULL
(	NULL
1	NULL
and	NULL
7	NULL
)	NULL
(	NULL
Li	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
Li	NULL
,	NULL
X.	NULL
L.	NULL
,	NULL
Duan	NULL
,	NULL
Z.	NULL
J.	NULL
,	NULL
Lee	NULL
,	NULL
O.	NULL
,	NULL
Lin	NULL
,	NULL
S.	NULL
,	NULL
Ma	NULL
,	NULL
Z.	NULL
M.	NULL
,	NULL
Chang	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Yang	NULL
,	NULL
X.	NULL
Y.	NULL
,	NULL
Park	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Mohandas	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
Noll	NULL
,	NULL
W.	NULL
,	NULL
Chan	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Chang	NULL
,	NULL
T.	NULL
Y	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
J.	NULL
Biol	NULL
Chem	NULL
.	NULL

274	NULL
,	NULL
11060-11071	NULL
)	NULL
.	NULL

Interferon-y	NULL
(	NULL
IFN-y	NULL
)	NULL
,	NULL
a	NULL
cyto-kine	NULL
that	NULL
exerts	NULL
many	NULL
pro-atherosclerotic	NULL
effects	NULL
in	NULL
vivo	NULL
,	NULL
causes	NULL
up-regulation	NULL
of	NULL
ACAT-1	NULL
mRNA	NULL
in	NULL
human	NULL
blood	NULL
monocyte-derived	NULL
macrophages	NULL
and	NULL
macrophage-like	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
molecular	NULL
nature	NULL
of	NULL
this	NULL
observation	NULL
,	NULL
we	NULL
identified	NULL
within	NULL
the	NULL
ACAT-1	NULL
P1	NULL
promoter	NULL
a	NULL
159-base	NULL
pair	NULL
core	NULL
region	NULL
.	NULL

This	NULL
region	NULL
contains	NULL
4	NULL
Spl	NULL
elements	NULL
and	NULL
an	NULL
IFN-y	NULL
activated	NULL
sequence	NULL
(	NULL
GAS	NULL
)	NULL
that	NULL
overlaps	NULL
with	NULL
the	NULL
second	NULL
Spl	NULL
element	NULL
.	NULL

In	NULL
the	NULL
monocytic	NULL
cell	NULL
line	NULL
THP	NULL
cell	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
IFN-y	NULL
and	NULL
all-trans-retinoic	NULL
acid	NULL
(	NULL
a	NULL
known	NULL
differentiation	NULL
agent	NULL
)	NULL
enhances	NULL
the	NULL
ACAT-1	NULL
P1	NULL
promoter	NULL
but	NULL
not	NULL
the	NULL
P7	NULL
promoter	NULL
.	NULL

Additional	NULL
experiments	NULL
showed	NULL
that	NULL
all-trans-retinoic	NULL
acid	NULL
causes	NULL
large	NULL
induction	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
STAT1	NULL
,	NULL
while	NULL
IFN-y	NULL
causes	NULL
activation	NULL
of	NULL
STAT1l	NULL
such	NULL
that	NULL
it	NULL
binds	NULL
to	NULL
the	NULL
GAS/Spl	NULL
site	NULL
in	NULL
the	NULL
ACAT-1	NULL
P1	NULL
promoter	NULL
.	NULL

Our	NULL
work	NULL
provides	NULL
a	NULL
molecular	NULL
mechanism	NULL
to	NULL
account	NULL
for	NULL
the	NULL
effect	NULL
of	NULL
IFN-y	NULL
in	NULL
causing	NULL
transcriptional	NULL
activation	NULL
of	NULL
ACAT-1	NULL
in	NULL
macrophage-like	NULL
cells	NULL
.	NULL

ACAT	NULL
is	NULL
an	NULL
intracellular	NULL
enzyme	NULL
responsible	NULL
for	NULL
catalyzing	NULL
the	NULL
intracellular	NULL
formation	NULL
of	NULL
cholesteryl	NULL
esters	NULL
from	NULL
choles-	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Natural	NULL
Scientific	NULL
Foundation	NULL
of	NULL
China	NULL
Grant	NULL
89425005	NULL
(	NULL
to	NULL
B.	NULL
L.	NULL
L.	NULL
)	NULL
,	NULL
Shanghai	NULL
Science	NULL
and	NULL
Technology	NULL
Commission	NULL
Grant	NULL
97XD14022	NULL
(	NULL
to	NULL
B.	NULL
L.	NULL
L.	NULL
)	NULL
,	NULL
and	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
HL	NULL
86709	NULL
(	NULL
to	NULL
T.	NULL
Y.	NULL
C.	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

«	NULL
To	NULL
whom	NULL
corresponding	NULL
may	NULL
be	NULL
addressed	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Biochemistry	NULL
,	NULL
Dartmouth	NULL
Medical	NULL
School	NULL
,	NULL
Hanover	NULL
,	NULL
NH	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
608-650-1622	NULL
;	NULL
Fax	NULL
:	NULL
603-650-1483	NULL
;	NULL
E-mail	NULL
:	NULL
Ta	NULL
.	NULL

Yuan.Chang	NULL
@	NULL
Dartmouth.EDU	NULL
.	NULL

|	NULL
To	NULL
whom	NULL
correspondence	NULL
may	NULL
be	NULL
addressed	NULL
:	NULL
Institute	NULL
of	NULL
Biochemistry	NULL
and	NULL
Cell	NULL
Biology	NULL
,	NULL
820	NULL
Yue-Yang	NULL
Road	NULL
,	NULL
Shanghai	NULL
2000831	NULL
,	NULL
China	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
86-21-6474-7085	NULL
;	NULL
Fax	NULL
:	NULL
86-21-6488-8857	NULL
;	NULL
E-mail	NULL
:	NULL
boliang	NULL
@	NULL
server.shene.ac.cn	NULL
.	NULL

'The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
ACAT	NULL
,	NULL
acyl-coenzyme	NULL
A	NULL
:	NULL
cholesterol	NULL
acyltransferase	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
GAS	NULL
,	NULL
IFN-y	NULL
activated	NULL
sequence	NULL
;	NULL
IFN-y	NULL
,	NULL
interferon-gamma	NULL
;	NULL
ATRA	NULL
,	NULL
all-frans-retinoic	NULL
acid	NULL
;	NULL
CHAPS	NULL
,	NULL
8-	NULL
[	NULL
(	NULL
8-cholamidopropyl	NULL
)	NULL
-dimethylammonio|-1-propanesulfonate	NULL
;	NULL
FBS	NULL
,	NULL
fetal	NULL
bovine	NULL
serum	NULL
;	NULL
PBS	NULL
,	NULL
phosphate-buffered	NULL
saline	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
;	NULL
RT-PCR	NULL
,	NULL
reverse	NULL
transcriptase-polymerase	NULL
chain	NULL
This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
terol	NULL
and	NULL
long-chain	NULL
fatty	NULL
acyl-coenzyme	NULL
A	NULL
(	NULL
1	NULL
)	NULL
.	NULL

In	NULL
mammals	NULL
,	NULL
two	NULL
ACAT	NULL
genes	NULL
have	NULL
been	NULL
identified	NULL
(	NULL
2-5	NULL
)	NULL
.	NULL

In	NULL
adult	NULL
human	NULL
tissues	NULL
,	NULL
ACAT-1	NULL
is	NULL
the	NULL
major	NULL
enzyme	NULL
present	NULL
in	NULL
various	NULL
tissues	NULL
,	NULL
including	NULL
macrophages	NULL
,	NULL
liver	NULL
(	NULL
hepatocytes	NULL
and	NULL
Kupffer	NULL
cells	NULL
)	NULL
,	NULL
and	NULL
adrenal	NULL
gland	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

ACAT-1	NULL
is	NULL
also	NULL
present	NULL
in	NULL
the	NULL
intestine	NULL
;	NULL
however	NULL
,	NULL
the	NULL
major	NULL
enzyme	NULL
involved	NULL
in	NULL
the	NULL
intestinal	NULL
cholesterol	NULL
absorption	NULL
may	NULL
be	NULL
ACAT-2	NULL
,	NULL
which	NULL
is	NULL
mainly	NULL
located	NULL
in	NULL
the	NULL
apical	NULL
region	NULL
of	NULL
the	NULL
intestinal	NULL
villi	NULL
(	NULL
7	NULL
)	NULL
.	NULL

The	NULL
relative	NULL
tissue	NULL
distributions	NULL
of	NULL
ACAT-1	NULL
and	NULL
ACAT-2	NULL
in	NULL
mice	NULL
and	NULL
monkeys	NULL
are	NULL
not	NULL
entirely	NULL
consistent	NULL
with	NULL
those	NULL
found	NULL
in	NULL
humans	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
raising	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
distribution	NULL
of	NULL
the	NULL
two	NULL
ACAT	NULL
's	NULL
in	NULL
various	NULL
tissues	NULL
may	NULL
be	NULL
species	NULL
dependent	NULL
.	NULL

In	NULL
macrophages	NULL
and	NULL
other	NULL
cell	NULL
types	NULL
,	NULL
a	NULL
dynamic	NULL
cholesterol-cholesteryl	NULL
ester	NULL
cycle	NULL
exist	NULL
;	NULL
the	NULL
formation	NULL
of	NULL
intracellular	NULL
cholesteryl	NULL
esters	NULL
is	NULL
catalyzed	NULL
by	NULL
ACAT-1	NULL
,	NULL
while	NULL
the	NULL
hydrolysis	NULL
of	NULL
cholesteryl	NULL
esters	NULL
is	NULL
catalyzed	NULL
by	NULL
the	NULL
enzyme	NULL
neutral	NULL
cholesteryl	NULL
ester	NULL
hydrolase	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

The	NULL
net	NULL
accumulation	NULL
of	NULL
intracellular	NULL
cholesteryl	NULL
esters	NULL
is	NULL
affected	NULL
at	NULL
the	NULL
substrate	NULL
level	NULL
,	NULL
as	NULL
well	NULL
as	NULL
at	NULL
the	NULL
levels	NULL
of	NULL
the	NULL
enzymes	NULL
ACAT	NULL
and	NULL
neutral	NULL
cholesteryl	NULL
ester	NULL
hydrolase	NULL
(	NULL
12-14	NULL
)	NULL
.	NULL

The	NULL
main	NULL
mode	NULL
of	NULL
sterol-specific	NULL
regulation	NULL
of	NULL
ACAT-1	NULL
has	NULL
been	NULL
identified	NULL
at	NULL
the	NULL
post-translational	NULL
level	NULL
,	NULL
involving	NULL
allosteric	NULL
regulation	NULL
by	NULL
its	NULL
substrate	NULL
cholesterol	NULL
(	NULL
1	NULL
,	NULL
15	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
cellular	NULL
and	NULL
molecular	NULL
nature	NULL
of	NULL
non-sterol-mediated	NULL
ACAT-1	NULL
regulation	NULL
remains	NULL
largely	NULL
unknown	NULL
.	NULL

Recently	NULL
,	NULL
using	NULL
mouse	NULL
macrophage-derived	NULL
foam	NULL
cells	NULL
,	NULL
Panousis	NULL
and	NULL
Zuckerman	NULL
(	NULL
12	NULL
)	NULL
reported	NULL
that	NULL
IFN-y	NULL
increased	NULL
the	NULL
cellular	NULL
cholesteryl	NULL
ester	NULL
content	NULL
and	NULL
reduced	NULL
high	NULL
density	NULL
lipoprotein-mediated	NULL
cholesterol	NULL
efflux	NULL
;	NULL
its	NULL
cellular	NULL
effects	NULL
were	NULL
attributed	NULL
to	NULL
its	NULL
ability	NULL
to	NULL
increase	NULL
ACAT	NULL
message	NULL
(	NULL
12	NULL
)	NULL
and	NULL
to	NULL
induce	NULL
down-regulation	NULL
of	NULL
the	NULL
Tangier	NULL
Disease	NULL
gene	NULL
(	NULL
the	NULL
ABC1	NULL
trans-porter	NULL
)	NULL
(	NULL
16	NULL
)	NULL
.	NULL

In	NULL
the	NULL
current	NULL
work	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
IFN-y	NULL
increased	NULL
ACAT-1	NULL
message	NULL
and	NULL
protein	NULL
content	NULL
in	NULL
human	NULL
monocyte-derived	NULL
macrophages	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
molecular	NULL
mechanism	NULL
of	NULL
IFN-y	NULL
action	NULL
on	NULL
ACAT-1	NULL
gene	NULL
regulation	NULL
in	NULL
macrophages	NULL
,	NULL
we	NULL
identified	NULL
the	NULL
important	NULL
cis-acting	NULL
elements	NULL
in	NULL
the	NULL
human	NULL
ACAT-1	NULL
P1	NULL
promoter	NULL
.	NULL

In	NULL
order	NULL
to	NULL
perform	NULL
transient	NULL
transfection	NULL
experiments	NULL
,	NULL
we	NULL
used	NULL
THP-1	NULL
cell	NULL
,	NULL
a	NULL
monocytic	NULL
human	NULL
cell	NULL
line	NULL
as	NULL
the	NULL
cell	NULL
model	NULL
.	NULL

Upon	NULL
treatment	NULL
with	NULL
retinoids	NULL
,	NULL
including	NULL
all-trans-retinoic	NULL
acid	NULL
(	NULL
ATRA	NULL
)	NULL
,	NULL
THP-1	NULL
cells	NULL
differentiate	NULL
into	NULL
macrophage-like	NULL
cells	NULL
(	NULL
17-20	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
ATRA	NULL
and	NULL
IFN-y	NULL
synergistically	NULL
caused	NULL
up-regulation	NULL
of	NULL
ACAT-1	NULL
gene	NULL
expression	NULL
.	NULL

Additional	NULL
experiments	NULL
revealed	NULL
that	NULL
ATRA	NULL
causes	NULL
increased	NULL
gene	NULL
expression	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
STAT1	NULL
,	NULL
while	NULL
IFN-y	NULL
is	NULL
essential	NULL
to	NULL
cause	NULL
reaction	NULL
;	NULL
GAPDH	NULL
,	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
;	NULL
knt	NULL
,	NULL
kelonucleotides	NULL
.	NULL

20989	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
20990	NULL
STAT1	NULL
to	NULL
undergo	NULL
phosphorylation	NULL
dependent	NULL
dimerization	NULL
and	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
GAS	NULL
site	NULL
present	NULL
in	NULL
the	NULL
ACAT-I	NULL
P1	NULL
promoter	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Cell	NULL
Culture	NULL
and	NULL
Treatments-Human	NULL
monocytes	NULL
were	NULL
isolated	NULL
according	NULL
to	NULL
a	NULL
published	NULL
procedure	NULL
(	NULL
21	NULL
)	NULL
with	NULL
slight	NULL
modification	NULL
:	NULL
human	NULL
leukocyte	NULL
packs	NULL
were	NULL
obtained	NULL
from	NULL
Shanghai	NULL
Blood	NULL
Service	NULL
Center	NULL
and	NULL
used	NULL
within	NULL
1	NULL
day	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
diluted	NULL
(	NULL
2:1	NULL
,	NULL
v/v	NULL
)	NULL
with	NULL
cold	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
layered	NULL
on	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
Ficoll-Paque	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
,	NULL
and	NULL
centrifuged	NULL
for	NULL
20	NULL
min	NULL
at	NULL
2,500	NULL
rpm	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Mononuclear	NULL
cells	NULL
were	NULL
collected	NULL
and	NULL
washed	NULL
three	NULL
times	NULL
at	NULL
4°C	NULL
(	NULL
to	NULL
remove	NULL
platelets	NULL
)	NULL
by	NULL
adding	NULL
100	NULL
ml	NULL
of	NULL
PBS	NULL
followed	NULL
by	NULL
centrifugation	NULL
at	NULL
1,000	NULL
rpm	NULL
for	NULL
10	NULL
min	NULL
.	NULL

The	NULL
remaining	NULL
red	NULL
blood	NULL
cells	NULL
in	NULL
the	NULL
pellet	NULL
were	NULL
lysed	NULL
by	NULL
treatment	NULL
with	NULL
10	NULL
ml	NULL
of	NULL
0.2	NULL
%	NULL
NaCl	NULL
for	NULL
45	NULL
s	NULL
,	NULL
followed	NULL
by	NULL
sequential	NULL
additions	NULL
of	NULL
10	NULL
ml	NULL
of	NULL
1.6	NULL
%	NULL
NaCl	NULL
and	NULL
30	NULL
ml	NULL
of	NULL
cold	NULL
PBS	NULL
.	NULL

The	NULL
pelleted	NULL
cells	NULL
were	NULL
suspended	NULL
in	NULL
cold	NULL
RPMI	NULL
1640	NULL
with	NULL
7	NULL
%	NULL
human	NULL
type	NULL
AB	NULL
serum	NULL
to	NULL
a	NULL
density	NULL
of	NULL
5	NULL
X	NULL
10°/ml	NULL
,	NULL
plated	NULL
onto	NULL
60-mm	NULL
tissue	NULL
culture	NULL
dishes	NULL
that	NULL
were	NULL
precoated	NULL
with	NULL
2	NULL
ml/dish	NULL
of	NULL
FBS	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
90	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Next	NULL
,	NULL
the	NULL
dishes	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
warm	NULL
RPMI	NULL
1640	NULL
(	NULL
37	NULL
°C	NULL
)	NULL
to	NULL
remove	NULL
unadhered	NULL
cells	NULL
.	NULL

The	NULL
adhered	NULL
cells	NULL
were	NULL
judged	NULL
to	NULL
be	NULL
more	NULL
than	NULL
95	NULL
%	NULL
monocytes	NULL
by	NULL
@	NULL
-naphthylacetate	NULL
esterase	NULL
staining	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
up	NULL
to	NULL
16	NULL
days	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
7	NULL
%	NULL
human	NULL
type	NULL
AB	NULL
serum	NULL
,	NULL
with	NULL
a	NULL
medium	NULL
change	NULL
every	NULL
other	NULL
day	NULL
.	NULL

Other	NULL
cell	NULL
lines	NULL
were	NULL
from	NULL
ATCC	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
60-mm	NULL
dishes	NULL
in	NULL
a	NULL
37	NULL
°C	NULL
incubator	NULL
with	NULL
5	NULL
%	NULL
atmospheric	NULL
CO	NULL
,	NULL
.	NULL

All	NULL
media	NULL
were	NULL
supplemented	NULL
with	NULL
100	NULL
ug/ml	NULL
kanamycin	NULL
,	NULL
50	NULL
units/ml	NULL
streptomycin	NULL
,	NULL
2	NULL
g/liters	NULL
sodium	NULL
bicarbon-ate	NULL
,	NULL
plus	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
FBS	NULL
)	NULL
.	NULL

THP-1	NULL
and	NULL
U937	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
.	NULL

HepG2	NULL
and	NULL
Caco-2	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
.	NULL

HEK293	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
minimal	NULL
essential	NULL
medium	NULL
medium	NULL
.	NULL

Chinese	NULL
hamster	NULL
ovary	NULL
cell	NULL
lines	NULL
AC29	NULL
and	NULL
25RA	NULL
(	NULL
22	NULL
,	NULL
28	NULL
)	NULL
were	NULL
grown	NULL
in	NULL
F12	NULL
medium	NULL
.	NULL

Reagents-Human	NULL
type	NULL
AB	NULL
serum	NULL
was	NULL
from	NULL
Sigma	NULL
.	NULL

Fetal	NULL
bovine	NULL
serum	NULL
was	NULL
obtained	NULL
from	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Purified	NULL
recombinant	NULL
human	NULL
IFN-y	NULL
(	NULL
1	NULL
X	NULL
10	NULL
``	NULL
units/mg	NULL
of	NULL
protein	NULL
)	NULL
was	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
Professor	NULL
Xin-yuan	NULL
Liu	NULL
(	NULL
24	NULL
)	NULL
at	NULL
the	NULL
Shanghai	NULL
Institute	NULL
of	NULL
Biochemistry	NULL
and	NULL
Cell	NULL
Biology	NULL
.	NULL

ATRA	NULL
was	NULL
from	NULL
Sigma	NULL
.	NULL

Rabbit	NULL
anti-Spl	NULL
(	NULL
PEP2	NULL
,	NULL
catalog	NULL
number	NULL
sc-59-G	NULL
,	NULL
200	NULL
ug/ml	NULL
)	NULL
and	NULL
anti-STAT1	NULL
(	NULL
C-111	NULL
,	NULL
catalog	NULL
number	NULL
sc-417	NULL
,	NULL
200	NULL
pg/ml	NULL
)	NULL
polyclonal	NULL
antibodies	NULL
were	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
.	NULL

[	NULL
a-	NULL
``	NULL
°P	NULL
]	NULL
-	NULL
and	NULL
[	NULL
y-*°P	NULL
]	NULL
dATP	NULL
(	NULL
6000	NULL
Ci/mmol	NULL
)	NULL
were	NULL
from	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
.	NULL

CHAPS	NULL
,	NULL
taurocholate	NULL
,	NULL
oleoyl-coenzyme	NULL
A	NULL
,	NULL
egg	NULL
phosphatidycholine	NULL
,	NULL
cholesteryl	NULL
oleate	NULL
,	NULL
cholesterol	NULL
,	NULL
and	NULL
fatty	NULL
acid-free	NULL
bovine	NULL
serum	NULL
albumin	NULL
were	NULL
all	NULL
from	NULL
Sigma	NULL
.	NULL

Reagent-grade	NULL
solvents	NULL
were	NULL
from	NULL
Fisher	NULL
.	NULL

[	NULL
°H	NULL
]	NULL
Oleoy	NULL
]	NULL
-coenzyme	NULL
A	NULL
was	NULL
chemically	NULL
synthesized	NULL
as	NULL
described	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Radioactive	NULL
reagents	NULL
were	NULL
from	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
.	NULL

Chimeric	NULL
Plasmid	NULL
Construction-The	NULL
682-bp	NULL
DNA	NULL
fragment	NULL
containing	NULL
the	NULL
human	NULL
ACAT-1	NULL
P1	NULL
promoter	NULL
(	NULL
-598/+84	NULL
)	NULL
(	NULL
26	NULL
)	NULL
was	NULL
inserted	NULL
into	NULL
the	NULL
multiple	NULL
cloning	NULL
sites	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
vector	NULL
pGL2-E	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

This	NULL
fragment	NULL
was	NULL
stepwise	NULL
deleted	NULL
from	NULL
both	NULL
ends	NULL
by	NULL
various	NULL
suitable	NULL
restriction	NULL
endonucleases	NULL
to	NULL
create	NULL
plasmids	NULL
that	NULL
contained	NULL
the	NULL
834	NULL
,	NULL
-188/+84	NULL
,	NULL
-125/+34	NULL
,	NULL
-598/-126	NULL
,	NULL
and	NULL
the	NULL
-598/	NULL
-189	NULL
fragments	NULL
,	NULL
respectively	NULL
.	NULL

Deletion	NULL
and	NULL
Site-directed	NULL
Mutagenesis	NULL
of	NULL
the	NULL
Sp1	NULL
and	NULL
GAS	NULL
Elements	NULL
in	NULL
ACAT-1	NULL
P1	NULL
Promoter	NULL
in	NULL
pGL2-E-Deletions	NULL
were	NULL
achieved	NULL
by	NULL
PCR-mediated	NULL
mutagenesis	NULL
using	NULL
the	NULL
corresponding	NULL
set	NULL
of	NULL
mutant	NULL
primers	NULL
that	NULL
included	NULL
a	NULL
6-bp	NULL
KpnI	NULL
or	NULL
NhelI	NULL
linker	NULL
flanking	NULL
the	NULL
primer	NULL
sequences	NULL
on	NULL
the	NULL
vector	NULL
.	NULL

The	NULL
primer	NULL
sequences	NULL
on	NULL
the	NULL
vector	NULL
are	NULL
:	NULL
GLP1	NULL
,	NULL
5'-TGT-ATCTTATGGTACTGTAACTG-3	NULL
'	NULL
;	NULL
GLP2	NULL
,	NULL
CTTCCA-3	NULL
'	NULL
.	NULL

The	NULL
primers	NULL
used	NULL
to	NULL
make	NULL
5'-	NULL
and	NULL
3'-deletion	NULL
mutations	NULL
(	NULL
to	NULL
generate	NULL
the	NULL
-110/+84	NULL
,	NULL
-100/+84	NULL
,	NULL
-100/-7	NULL
,	NULL
-100/-17	NULL
,	NULL
and	NULL
the	NULL
-100/-27	NULL
fragments	NULL
)	NULL
were	NULL
5'-aaaggtaccGGTGGGCGGAAC-3	NULL
'	NULL
,	NULL
5-aaa-ggtaccACTGGCAACCTG-3	NULL
'	NULL
,	NULL
5'-aaagetagCcCGGCCCCTACGC-3	NULL
'	NULL
,	NULL
5-aa-agetagCcGCCCCCTGCCTC-3	NULL
'	NULL
,	NULL
and	NULL
5'-aaagetagCTCCGAGCACCGC-3	NULL
'	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
PCR	NULL
products	NULL
were	NULL
then	NULL
digested	NULL
with	NULL
KprI	NULL
and	NULL
Nhel	NULL
and	NULL
subcloned	NULL
into	NULL
an	NULL
empty	NULL
pGL2-E	NULL
vector	NULL
.	NULL

The	NULL
fidelity	NULL
of	NULL
all	NULL
these	NULL
constructs	NULL
was	NULL
verified	NULL
by	NULL
sequencing	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
was	NULL
undertaken	NULL
using	NULL
a	NULL
modification	NULL
of	NULL
the	NULL
procedure	NULL
described	NULL
by	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

(	NULL
27	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
two	NULL
overlapping	NULL
fragments	NULL
of	NULL
the	NULL
promoter	NULL
subcloned	NULL
into	NULL
the	NULL
pGL2-E	NULL
vector	NULL
were	NULL
amplified	NULL
separately	NULL
.	NULL

The	NULL
first	NULL
reaction	NULL
used	NULL
a	NULL
flanking	NULL
primer	NULL
that	NULL
hybridized	NULL
with	NULL
the	NULL
vector	NULL
at	NULL
the	NULL
5'-end	NULL
of	NULL
the	NULL
inserted	NULL
sequence	NULL
,	NULL
and	NULL
an	NULL
internal	NULL
primer	NULL
that	NULL
hybridized	NULL
at	NULL
the	NULL
site	NULL
of	NULL
the	NULL
desired	NULL
mutation	NULL
and	NULL
contained	NULL
the	NULL
mismatched	NULL
base	NULL
.	NULL

The	NULL
second	NULL
reaction	NULL
included	NULL
one	NULL
flanking	NULL
primer	NULL
that	NULL
hybridized	NULL
with	NULL
the	NULL
vector	NULL
at	NULL
the	NULL
3'-end	NULL
of	NULL
the	NULL
inserted	NULL
sequence	NULL
,	NULL
and	NULL
an	NULL
internal	NULL
primer	NULL
that	NULL
overlapped	NULL
with	NULL
the	NULL
site	NULL
of	NULL
the	NULL
desired	NULL
mutation	NULL
and	NULL
also	NULL
contained	NULL
the	NULL
mismatched	NULL
base	NULL
.	NULL

The	NULL
two	NULL
overlapping	NULL
fragments	NULL
generated	NULL
by	NULL
PCR	NULL
Activation	NULL
of	NULL
ACAT-1	NULL
by	NULL
IFN-y	NULL
in	NULL
Foam	NULL
Cell	NULL
Formation	NULL
are	NULL
``	NULL
fused	NULL
``	NULL
by	NULL
denaturing	NULL
and	NULL
annealing	NULL
in	NULL
a	NULL
subsequent	NULL
primer	NULL
extension	NULL
reaction	NULL
.	NULL

Finally	NULL
the	NULL
``	NULL
fusion	NULL
``	NULL
product	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
using	NULL
the	NULL
primers	NULL
GLP1	NULL
and	NULL
GLP2	NULL
.	NULL

The	NULL
product	NULL
of	NULL
the	NULL
final	NULL
PCR	NULL
was	NULL
digested	NULL
with	NULL
KpnI	NULL
and	NULL
NheI	NULL
and	NULL
subcloned	NULL
into	NULL
the	NULL
pGL2-E	NULL
vector	NULL
.	NULL

To	NULL
guard	NULL
against	NULL
PCR-associated	NULL
nucleotide	NULL
incorporation	NULL
errors	NULL
,	NULL
the	NULL
integrity	NULL
of	NULL
all	NULL
the	NULL
constructs	NULL
generated	NULL
was	NULL
sequenced	NULL
using	NULL
an	NULL
automated	NULL
ABI	NULL
Prism	NULL
377	NULL
DNA	NULL
sequencer	NULL
(	NULL
Perkin-Elmer	NULL
Applied	NULL
Biosystems	NULL
,	NULL
Canada	NULL
Inc.	NULL
,	NULL
Mississaug	NULL
,	NULL
ON	NULL
)	NULL
.	NULL

To	NULL
generate	NULL
the	NULL
fragments	NULL
Spl-lm	NULL
,	NULL
Spl-2m	NULL
,	NULL
Sp1l-8m	NULL
,	NULL
Spl-4m	NULL
,	NULL
and	NULL
GASm	NULL
,	NULL
respectively	NULL
,	NULL
the	NULL
following	NULL
sets	NULL
of	NULL
primer	NULL
pairs	NULL
were	NULL
used	NULL
:	NULL
5'-CCTCCCCGTTCCGGTACCTCCCC-8'/5'-GGGGAGGTACCGGAACGGGGAGG-3	NULL
'	NULL
,	NULL
5'-CAGTTCCGTTCACCTCC-CCGCC-3'/5-GGCGGGGAGGTGAACGGAACTG-3	NULL
'	NULL
,	NULL
5'-GAGGCAGG-5'-	NULL
5-GTTGCCAGCCCCGCCCACCTCC-3'/5-GGAGGTGGGC-GGGGCTGGCAAC-3	NULL
'	NULL
.	NULL

For	NULL
additional	NULL
mutagenesis	NULL
work	NULL
,	NULL
we	NULL
used	NULL
Spl-lm	NULL
as	NULL
the	NULL
template	NULL
and	NULL
5-CAGTTCCGTTCACCTCCCCGTT-3/5	NULL
as	NULL
the	NULL
primer	NULL
pair	NULL
to	NULL
generate	NULL
Sp1l-12m	NULL
,	NULL
used	NULL
Spl-12m	NULL
as	NULL
the	NULL
template	NULL
and	NULL
5'-GAGGCAG-GAAGCGTAGGGGCCG-3'/5-CGGCCCCTACGCTTCCTGCCTC-3	NULL
'	NULL
as	NULL
the	NULL
primer	NULL
pair	NULL
to	NULL
generate	NULL
Sp1l-123m	NULL
,	NULL
used	NULL
Sp1l-123m	NULL
as	NULL
the	NULL
template	NULL
and	NULL
5'-AAGCGTAGAAGCCGGGCTGTCC-3'/5-GGACAGCCCGGCTT-CTACGCTT-3	NULL
'	NULL
as	NULL
the	NULL
primer	NULL
pair	NULL
to	NULL
generate	NULL
Sp1l-1234m	NULL
.	NULL

STAT1	NULL
Mutant	NULL
Expression	NULL
Plasmid-The	NULL
human	NULL
STAT1	NULL
cDNA	NULL
(	NULL
en-coding	NULL
the	NULL
750	NULL
amino	NULL
acids	NULL
of	NULL
STAT1	NULL
protein	NULL
)	NULL
in	NULL
pRC/CMV	NULL
(	NULL
pRC/CMV-STAT1	NULL
)	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
Darnell	NULL
(	NULL
Rockefeller	NULL
University	NULL
)	NULL
.	NULL

The	NULL
mutant	NULL
STATI	NULL
expression	NULL
plasmid	NULL
was	NULL
created	NULL
using	NULL
the	NULL
site-directed	NULL
mutagenesis	NULL
procedure	NULL
of	NULL
Ho	NULL
ef	NULL
al	NULL
.	NULL

(	NULL
27	NULL
)	NULL
.	NULL

Two	NULL
sets	NULL
of	NULL
primers	NULL
5'-GGAGAGAAGCTTCTTGGT-3'/5-CTGAAGTCTAGAAGGGTG-3	NULL
'	NULL
and	NULL
5'-AAGGAACTGGATTTATCAAGACTGA-3/5'-TCAGTCTTGATA-AATCCAGTTCCTT-3	NULL
'	NULL
were	NULL
used	NULL
to	NULL
mutate	NULL
STAT1	NULL
at	NULL
amino	NULL
acid	NULL
701	NULL
(	NULL
the	NULL
Jak1/2	NULL
phosphorylation	NULL
site	NULL
)	NULL
from	NULL
tyrosine	NULL
to	NULL
phenylalanine	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
plasmid	NULL
pRC/CMV-STAT1-Y701Fm	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
the	NULL
mutant	NULL
PCR	NULL
product	NULL
digested	NULL
with	NULL
HindII/Xbal	NULL
into	NULL
the	NULL
same	NULL
sites	NULL
of	NULL
pRC/CMV	NULL
.	NULL

Transfection	NULL
and	NULL
Luciferase	NULL
Assay-A	NULL
series	NULL
of	NULL
ACAT	NULL
Pl	NULL
promoter/	NULL
luciferase	NULL
reporter	NULL
(	NULL
Luc	NULL
)	NULL
constructs	NULL
were	NULL
transfected	NULL
into	NULL
THP-1	NULL
or	NULL
U937	NULL
cells	NULL
using	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
(	NULL
29	NULL
,	NULL
80	NULL
)	NULL
.	NULL

After	NULL
washing	NULL
twice	NULL
with	NULL
PBS	NULL
,	NULL
1	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
1.5	NULL
ug	NULL
of	NULL
ACAT-1	NULL
promoter/Luc	NULL
plasmid	NULL
and	NULL
0.75	NULL
ug	NULL
pCH110	NULL
as	NULL
internal	NULL
control	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
STBE	NULL
(	NULL
25	NULL
mm	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
5	NULL
mM	NULL
KCl	NULL
,	NULL
0.7	NULL
mM	NULL
CaCl	NULL
,	NULL
,	NULL
187	NULL
mM	NULL
NaCl	NULL
,	NULL
0.6	NULL
mM	NULL
Na	NULL
,	NULL
HPO	NULL
,	NULL
,	NULL
0.5	NULL
mM	NULL
MgC	NULL
]	NULL
,	NULL
)	NULL
containing	NULL
150	NULL
ug	NULL
of	NULL
DEAE-dextran	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
20	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
,	NULL
washed	NULL
once	NULL
with	NULL
RPMI	NULL
1640	NULL
without	NULL
FBS	NULL
,	NULL
then	NULL
resuspended	NULL
in	NULL
5	NULL
ml	NULL
of	NULL
fresh	NULL
RPMI	NULL
1640	NULL
with	NULL
10	NULL
%	NULL
FBS	NULL
,	NULL
and	NULL
plated	NULL
at	NULL
2	NULL
X	NULL
10°	NULL
cells/ml/well	NULL
in	NULL
a	NULL
24-well	NULL
plate	NULL
for	NULL
40	NULL
h.	NULL
HepG2	NULL
,	NULL
CACO-2	NULL
,	NULL
and	NULL
HEK293	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
methods	NULL
of	NULL
calcium	NULL
phosphate	NULL
co-precipitation	NULL
essentially	NULL
as	NULL
described	NULL
by	NULL
Liu	NULL
et	NULL
al	NULL
.	NULL

(	NULL
31	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
plated	NULL
at	NULL
1	NULL
X	NULL
10°	NULL
cells/well	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
medium	NULL
in	NULL
24-well	NULL
tissue	NULL
culture	NULL
plates	NULL
1	NULL
day	NULL
before	NULL
transfection	NULL
.	NULL

One	NULL
h	NULL
before	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
replaced	NULL
with	NULL
fresh	NULL
medium	NULL
.	NULL

Calcium	NULL
phosphate	NULL
precipitates	NULL
containing	NULL
(	NULL
per	NULL
well	NULL
)	NULL
0.3	NULL
ug	NULL
of	NULL
ACAT-1	NULL
promoter/Luc	NULL
and	NULL
0.15	NULL
ug	NULL
of	NULL
pCH110	NULL
were	NULL
prepared	NULL
.	NULL

The	NULL
DNA/calcium	NULL
phosphate	NULL
precipitates	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
cells	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
8	NULL
h	NULL
,	NULL
after	NULL
which	NULL
time	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
once	NULL
with	NULL
PBS	NULL
,	NULL
and	NULL
replaced	NULL
with	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
or	NULL
minimal	NULL
essential	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
FBS	NULL
.	NULL

After	NULL
incubation	NULL
for	NULL
7	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
IFN-y	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
,	NULL
or	NULL
ATRA	NULL
(	NULL
10~®	NULL
M	NULL
)	NULL
,	NULL
or	NULL
IFN-y	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
plus	NULL
ATRA	NULL
(	NULL
10~°	NULL
M	NULL
)	NULL
.	NULL

40	NULL
h	NULL
later	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
the	NULL
cell	NULL
pellets	NULL
were	NULL
lysed	NULL
in	NULL
200	NULL
ul	NULL
of	NULL
lysis	NULL
buffer	NULL
(	NULL
Reporter	NULL
lysis	NULL
buffer	NULL
,	NULL
Pro-mega	NULL
,	NULL
catalog	NULL
number	NULL
E397A	NULL
)	NULL
,	NULL
vortexed	NULL
for	NULL
5	NULL
s	NULL
,	NULL
and	NULL
spun	NULL
at	NULL
2000	NULL
%	NULL
g	NULL
for	NULL
5	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

60	NULL
pl	NULL
of	NULL
the	NULL
cell	NULL
lysate	NULL
was	NULL
mixed	NULL
with	NULL
60	NULL
pil	NULL
of	NULL
luciferase	NULL
assay	NULL
buffer	NULL
(	NULL
Promega	NULL
)	NULL
for	NULL
luciferase	NULL
activity	NULL
measurement	NULL
(	NULL
Promega	NULL
Instruction	NULL
Bulletin	NULL
Part	NULL
number	NULL
TB101	NULL
)	NULL
in	NULL
an	NULL
Auto	NULL
Lumat	NULL
BG-P	NULL
luminometer	NULL
(	NULL
MGM	NULL
Instrument	NULL
Inc.	NULL
)	NULL
.	NULL

For	NULL
B-galactosidase	NULL
activity	NULL
assay	NULL
,	NULL
the	NULL
luminescent	NULL
B-galactosidase	NULL
detection	NULL
Kit	NULL
II	NULL
was	NULL
used	NULL
(	NULL
CLONTECH	NULL
User	NULL
Manual	NULL
PT2106-1	NULL
)	NULL
.	NULL

Reverse	NULL
Transcription-Polymerase	NULL
Chain	NULL
Rreaction-The	NULL
total	NULL
RNA	NULL
(	NULL
4	NULL
ug	NULL
)	NULL
prepared	NULL
according	NULL
to	NULL
the	NULL
single	NULL
step	NULL
acid	NULL
guanidinium	NULL
thiocyanate	NULL
phenol	NULL
chloroform	NULL
method	NULL
(	NULL
Trizol	NULL
Regent	NULL
,	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
was	NULL
annealed	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
(	NULL
12-18	NULL
in	NULL
length	NULL
)	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
20	NULL
pl	NULL
and	NULL
reverse	NULL
transcribed	NULL
with	NULL
5	NULL
units	NULL
of	NULL
avian	NULL
myeloblastosis	NULL
virus	NULL
reverse	NULL
transcriptase	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
at	NULL
42	NULL
°C	NULL
for	NULL
50	NULL
min	NULL
,	NULL
and	NULL
then	NULL
diluted	NULL
to	NULL
a	NULL
volume	NULL
of	NULL
80	NULL
pl	NULL
as	NULL
the	NULL
ss-cDNA	NULL
product	NULL
.	NULL

The	NULL
4	NULL
ul	NULL
of	NULL
diluted	NULL
ss-cDNA	NULL
product	NULL
was	NULL
added	NULL
to	NULL
a	NULL
reaction	NULL
mixture	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
20	NULL
pl	NULL
containing	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
8.3	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
KCl	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
mM	NULL
dNTP	NULL
,	NULL
0.5	NULL
mM	NULL
each	NULL
pair	NULL
of	NULL
primers	NULL
,	NULL
and	NULL
1	NULL
unit	NULL
of	NULL
Tag	NULL
DNA	NULL
polymerase	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

To	NULL
serve	NULL
as	NULL
controls	NULL
,	NULL
GAPDH	NULL
gene	NULL
expression	NULL
was	NULL
assessed	NULL
to	NULL
ascertain	NULL
that	NULL
equal	NULL
amounts	NULL
of	NULL
cDNA	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Activation	NULL
of	NULL
ACAT-1	NULL
by	NULL
IFN-y	NULL
in	NULL
Foam	NULL
Cell	NULL
Formation	NULL
A	NULL
Relative	NULL
luciferase	NULL
activity	NULL
(	NULL
fold	NULL
)	NULL
1598	NULL
P1	NULL
promoter	NULL
evi	NULL
-324	NULL
-188	NULL
I	NULL
-125	NULL
-_-	NULL
-y	NULL
-126	NULL
-189	NULL
[	NULL
mmm	NULL
Chs	NULL
)	NULL
C	NULL
--	NULL
ms	NULL
SV40	NULL
Promoter	NULL
B	NULL
Sma	NULL
I	NULL
(	NULL
+125	NULL
)	NULL
cmescecces	NULL
seacccocec	NULL
CCCJGGGAAG	NULL
Eecsceckeac	NULL
crlecccegha	NULL
-	NULL
-100	NULL
Spt	NULL
Spl	NULL
CTGGCAACCT	NULL
GGGGACCACC	NULL
AATAGGATGC	NULL
TCAGCCGGAG	NULL
GTGGcccTrec	NULL
-50	NULL
-	NULL
a	NULL
GCGTGaAceca	NULL
Gceetectce	NULL
cacccacfee	NULL
ccopmacfeec	NULL
cepecrercc	NULL
+1	NULL
Spl	NULL
Spl	NULL
+1	NULL
#	NULL
#	NULL
GGCGCTTTAG	NULL
CTTAGCAGGC	NULL
CACGTTGCGG	NULL
GCCCTGGGCG	NULL
CCAGGAGAGC	NULL
+51	NULL
3	NULL
Apa	NULL
I	NULL
(	NULL
+34	NULL
)	NULL
TTCCCGGAGT	NULL
CCAC	NULL
+65	NULL
Exon	NULL
1	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

A	NULL
159-bp	NULL
core	NULL
region	NULL
comprises	NULL
the	NULL
basal	NULL
transcriptional	NULL
activity	NULL
of	NULL
ACAT-I	NULL
P1	NULL
promoter	NULL
.	NULL

A	NULL
,	NULL
Luc	NULL
constructs	NULL
(	NULL
bars	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
panel	NULL
)	NULL
containing	NULL
serial	NULL
5	NULL
'	NULL
and	NULL
3	NULL
``	NULL
deletions	NULL
as	NULL
indicated	NULL
between	NULL
-598	NULL
and	NULL
+84	NULL
of	NULL
the	NULL
ACAT-1	NULL
P1	NULL
promoter	NULL
were	NULL
co-transfected	NULL
with	NULL
pCH110	NULL
into	NULL
THP-1	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
harvested	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
for	NULL
activity	NULL
assays	NULL
.	NULL

The	NULL
luciferase	NULL
activity	NULL
per	NULL
each	NULL
cell	NULL
extract	NULL
was	NULL
normalized	NULL
by	NULL
using	NULL
the	NULL
B-galactosidase	NULL
value	NULL
found	NULL
in	NULL
the	NULL
same	NULL
cell	NULL
extract	NULL
.	NULL

The	NULL
reporter	NULL
construct	NULL
activities	NULL
shown	NULL
on	NULL
the	NULL
right	NULL
panel	NULL
were	NULL
expressed	NULL
as	NULL
relative	NULL
luciferase	NULL
activities	NULL
,	NULL
using	NULL
the	NULL
value	NULL
of	NULL
the	NULL
reporter	NULL
activity	NULL
driven	NULL
by	NULL
the	NULL
SV40	NULL
promoter	NULL
as	NULL
one	NULL
.	NULL

Values	NULL
were	NULL
means	NULL
of	NULL
triplicate	NULL
determinations	NULL
.	NULL

Sizes	NULL
of	NULL
error	NULL
bars	NULL
indicated	NULL
1	NULL
S.E	NULL
.	NULL

B	NULL
,	NULL
nucleotide	NULL
sequence	NULL
analysis	NULL
of	NULL
ACAT-1	NULL
P1	NULL
promoter	NULL
core	NULL
region	NULL
.	NULL

The	NULL
four	NULL
Spl	NULL
elements	NULL
were	NULL
boxed	NULL
.	NULL

Asterisks	NULL
indicate	NULL
the	NULL
three	NULL
major	NULL
transcriptional	NULL
initiation	NULL
sites	NULL
(	NULL
Li	NULL
et	NULL
al	NULL
.	NULL

(	NULL
26	NULL
)	NULL
)	NULL
.	NULL

Sequence	NULL
of	NULL
Exon	NULL
1	NULL
was	NULL
underlined	NULL
.	NULL

were	NULL
added	NULL
to	NULL
each	NULL
PCR	NULL
.	NULL

The	NULL
PCR	NULL
products	NULL
(	NULL
10	NULL
ul	NULL
)	NULL
,	NULL
taken	NULL
at	NULL
several	NULL
different	NULL
cycles	NULL
(	NULL
from	NULL
26	NULL
to	NULL
32	NULL
)	NULL
,	NULL
were	NULL
separated	NULL
in	NULL
agarose	NULL
gel	NULL
and	NULL
quantified	NULL
by	NULL
using	NULL
the	NULL
UVP	NULL
Labwork	NULL
Software	NULL
(	NULL
UVP	NULL
Inc.	NULL
)	NULL
.	NULL

The	NULL
sets	NULL
of	NULL
primers	NULL
used	NULL
are	NULL
5'-AAAGGAGTCCCTAGAG-3'/5-GGATGAGAACTC-TTGC-3	NULL
'	NULL
for	NULL
ACAT-1	NULL
P1	NULL
product	NULL
(	NULL
hACAT-1	NULL
eDNA	NULL
K1	NULL
1486-2043	NULL
,	NULL
amplifying	NULL
a	NULL
558-bp	NULL
fragment	NULL
)	NULL
,	NULL
5-ACCCACCATTATCTAA-3'/5'-ACC-CACCATTATCTAA-3	NULL
'	NULL
for	NULL
human	NULL
ACAT	NULL
P7	NULL
product	NULL
cDNA	NULL
K1	NULL
982-1670	NULL
,	NULL
amplifying	NULL
a	NULL
689-bp	NULL
fragment	NULL
)	NULL
(	NULL
2	NULL
,	NULL
26	NULL
)	NULL
,	NULL
5'-GCCCGAC-CCTATTACAAAAA-3/5'-CTGCCAACTCAACACCTCTG-3	NULL
'	NULL
for	NULL
STAT1	NULL
coding	NULL
sequence	NULL
(	NULL
amplifying	NULL
a	NULL
646-bp	NULL
fragment	NULL
)	NULL
(	NULL
82	NULL
)	NULL
and	NULL
5'-GAGTCAACGGATTTGGTCG-3'/5-GAAGTGGTGGTACCTCTTCC-3	NULL
'	NULL
for	NULL
GAPDH	NULL
(	NULL
amplifying	NULL
a	NULL
291-bp	NULL
fragment	NULL
)	NULL
(	NULL
82	NULL
)	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assays	NULL
(	NULL
EMSAs	NULL
)	NULL
-Nuclear	NULL
extract	NULL
was	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
83	NULL
)	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
washed	NULL
twice	NULL
with	NULL
cold	NULL
PBS	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
and	NULL
resuspended	NULL
gently	NULL
in	NULL
400	NULL
pl	NULL
of	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mym	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
10	NULL
mM	NULL
KCl	NULL
,	NULL
1.5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.2	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
)	NULL
,	NULL
and	NULL
stored	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
,	NULL
then	NULL
vortexed	NULL
for	NULL
10	NULL
s.	NULL
Nuclei	NULL
were	NULL
pelleted	NULL
(	NULL
10,000	NULL
x	NULL
g	NULL
,	NULL
10	NULL
s	NULL
)	NULL
,	NULL
resuspended	NULL
with	NULL
ice-cold	NULL
buffer	NULL
C	NULL
(	NULL
20	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
420	NULL
mM	NULL
NaCl	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.2	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
)	NULL
,	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
20	NULL
min	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
subjected	NULL
to	NULL
centrifugation	NULL
(	NULL
10,000	NULL
X	NULL
g	NULL
)	NULL
for	NULL
2	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
and	NULL
the	NULL
supernatant	NULL
as	NULL
nuclear	NULL
extract	NULL
was	NULL
stored	NULL
in	NULL
aliquots	NULL
at	NULL
-80	NULL
°C	NULL
.	NULL

For	NULL
EMSA	NULL
,	NULL
10	NULL
pg	NULL
of	NULL
protein	NULL
of	NULL
nuclear	NULL
extract	NULL
was	NULL
incubated	NULL
for	NULL
10	NULL
min	NULL
on	NULL
ice	NULL
in	NULL
10	NULL
l	NULL
of	NULL
binding	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
1	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
4	NULL
%	NULL
glycerol	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.5	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
3	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI	NULL
)	NULL
-	NULL
(	NULL
dC	NULL
)	NULL
from	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
Inc.	NULL
)	NULL
.	NULL

DNA	NULL
probes	NULL
were	NULL
labeled	NULL
using	NULL
T	NULL
,	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
Promega	NULL
)	NULL
and	NULL
[	NULL
y-*°P	NULL
]	NULL
dATP	NULL
.	NULL

1	NULL
ng	NULL
of	NULL
labeled	NULL
probe	NULL
(	NULL
~1	NULL
x	NULL
10	NULL
``	NULL
dpm	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
mixture	NULL
and	NULL
incubated	NULL
at	NULL
25	NULL
°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

For	NULL
``	NULL
supershift	NULL
``	NULL
analyses	NULL
,	NULL
1	NULL
pl	NULL
of	NULL
each	NULL
antibody	NULL
as	NULL
indicated	NULL
was	NULL
added	NULL
and	NULL
20991	NULL
A	NULL
Relative	NULL
luciferase	NULL
activity	NULL
(	NULL
fold	NULL
)	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
PI	NULL
promoter	NULL
Sp1	NULL
.	NULL

Spl	NULL
Sp1	NULL
.	NULL

Spl	NULL
I	NULL
11	NULL
|	NULL
A	NULL
A	NULL
A	NULL
B	NULL
promoterless	NULL
SV40	NULL
promoter	NULL
Relative	NULL
luciferase	NULL
activity	NULL
(	NULL
fold	NULL
)	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
PI	NULL
promoter	NULL
Sp1	NULL
Spl	NULL
Spi	NULL
Spl	NULL
-	NULL
mas	NULL
hs	NULL
Com-	NULL
sxc	NULL
ths	NULL
)	NULL
promoterless	NULL
CBee	NULL
SV40	NULL
promoter	NULL
C	NULL
€	NULL
€	NULL
Spl-1234-Mutant	NULL
_A	NULL
N	NULL
/	NULL
Anti-Spl	NULL
antibody	NULL
1.5	NULL
ug	NULL
pGL2-E	NULL
100	NULL
ng	NULL
cold	NULL
probe	NULL
10	NULL
pg	NULL
nuclear	NULL
extract	NULL
3	NULL
ug	NULL
poly	NULL
(	NULL
dl-dC	NULL
)	NULL
I	NULL
ng	NULL
[	NULL
``	NULL
P	NULL
]	NULL
-labeled	NULL
probe	NULL
+	NULL
+	NULL
+	NULL
r	NULL
dod	NULL
+4	NULL
40d	NULL
goa	NULL
++	NULL
4	NULL
4	NULL
ron	NULL
}	NULL
%	NULL
*+	NULL
#	NULL
#	NULL
1	NULL
#	NULL
ou	NULL
++	NULL
4	NULL
iod	NULL
+4	NULL
d	NULL
d	NULL
dod	NULL
+	NULL
4	NULL
4	NULL
1	NULL
a	NULL
+o	NULL
#	NULL
#	NULL
4	NULL
dod	NULL
++	NULL
4	NULL
oi	NULL
#	NULL
u	NULL
+4	NULL
4	NULL
bol	NULL
+	NULL
``	NULL
UH	NULL
t	NULL
lal	NULL
Spl	NULL
SpI	NULL
Spt	NULL
Spl	NULL
H	NULL
N	NULL
Com-	NULL
mm	NULL
``	NULL
Wild	NULL
xE	NULL
``	NULL
Spl-1234-Mutant	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Four	NULL
Spl	NULL
elements	NULL
are	NULL
functionally	NULL
present	NULL
in	NULL
ACAT-1	NULL
P1	NULL
promoter	NULL
.	NULL

A	NULL
,	NULL
Luc	NULL
constructs	NULL
containing	NULL
serial	NULL
5'-	NULL
and	NULL
3'-deletion	NULL
(	NULL
bars	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
)	NULL
of	NULL
the	NULL
159-bp	NULL
core	NULL
region	NULL
were	NULL
transfected	NULL
into	NULL
THP-1	NULL
cells	NULL
.	NULL

The	NULL
luciferase	NULL
activities	NULL
(	NULL
shown	NULL
on	NULL
right	NULL
)	NULL
were	NULL
determined	NULL
in	NULL
the	NULL
same	NULL
manner	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

14	NULL
.	NULL

The	NULL
promoterless	NULL
plasmid	NULL
pGL2-E	NULL
was	NULL
used	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
.	NULL

B	NULL
,	NULL
Luc	NULL
constructs	NULL
containing	NULL
single	NULL
or	NULL
multiple	NULL
Spl	NULL
mutations	NULL
(	NULL
marked	NULL
by	NULL
the	NULL
X	NULL
)	NULL
of	NULL
the	NULL
159-bp	NULL
core	NULL
region	NULL
were	NULL
transfected	NULL
into	NULL
THP-1	NULL
cells	NULL
.	NULL

The	NULL
luciferase	NULL
activities	NULL
shown	NULL
on	NULL
right	NULL
panel	NULL
were	NULL
determined	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

14	NULL
.	NULL

C	NULL
,	NULL
EMSAs	NULL
using	NULL
nuclear	NULL
extracts	NULL
of	NULL
THP-1	NULL
cells	NULL
.	NULL

The	NULL
wild-type	NULL
and	NULL
Sp1l-1234-mutant	NULL
DNA	NULL
fragments	NULL
of	NULL
ACAT-1	NULL
P1	NULL
promoter	NULL
(	NULL
depicted	NULL
at	NULL
the	NULL
Zeft	NULL
panel	NULL
)	NULL
were	NULL
,	NULL
respectively	NULL
,	NULL
labeled	NULL
and	NULL
1	NULL
10*	NULL
dpm	NULL
of	NULL
labeled	NULL
probe	NULL
was	NULL
used	NULL
for	NULL
each	NULL
binding	NULL
reaction	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
°°P-labeled	NULL
wild-type	NULL
DNA	NULL
as	NULL
probe	NULL
alone	NULL
.	NULL

Lane	NULL
2	NULL
,	NULL
binding	NULL
reaction	NULL
between	NULL
labeled	NULL
wild-type	NULL
DNA	NULL
probe	NULL
and	NULL
nuclear	NULL
extracts	NULL
.	NULL

Lane	NULL
3	NULL
,	NULL
competition	NULL
by	NULL
adding	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
cold	NULL
probe	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
described	NULL
for	NULL
lane	NULL
2	NULL
.	NULL

Lane	NULL
4	NULL
,	NULL
competition	NULL
by	NULL
adding	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
nonspecific	NULL
DNA	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
described	NULL
for	NULL
lane	NULL
2	NULL
.	NULL

Lane	NULL
5	NULL
,	NULL
supershift	NULL
reaction	NULL
by	NULL
adding	NULL
1	NULL
pl	NULL
of	NULL
anti-Sp1l	NULL
antibody	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
described	NULL
for	NULL
lane	NULL
2	NULL
.	NULL

Lanes	NULL
6-10	NULL
,	NULL
the	NULL
same	NULL
conditions	NULL
as	NULL
described	NULL
for	NULL
lanes	NULL
1-5	NULL
,	NULL
except	NULL
using	NULL
the	NULL
Sp1l-1284-mu-tant	NULL
DNA	NULL
as	NULL
the	NULL
labeled	NULL
probe	NULL
.	NULL

incubated	NULL
30	NULL
min	NULL
at	NULL
25	NULL
°C	NULL
before	NULL
adding	NULL
the	NULL
probe	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
size	NULL
fractionated	NULL
on	NULL
a	NULL
nondenaturing	NULL
4.5	NULL
%	NULL
acrylamide	NULL
gel	NULL
(	NULL
29:1	NULL
,	NULL
mass	NULL
:	NULL
mass	NULL
,	NULL
acrylamide	NULL
:	NULL
N	NULL
,	NULL
N'-methylenebisacrylamide	NULL
)	NULL
,	NULL
ran	NULL
at	NULL
200	NULL
V	NULL
for	NULL
3	NULL
h	NULL
in	NULL
0.5	NULL
X	NULL
TBE	NULL
buffer	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
dried	NULL
and	NULL
autoradiographed	NULL
with	NULL
PhosphorImager	NULL
scanning	NULL
system	NULL
.	NULL

RNA	NULL
Preparation	NULL
and	NULL
Northern	NULL
Blot	NULL
Analysis-THP-1	NULL
cells	NULL
were	NULL
cultured	NULL
at	NULL
2	NULL
X	NULL
10°/ml	NULL
in	NULL
60-mm	NULL
dishes	NULL
.	NULL

Human	NULL
blood	NULL
monocytes	NULL
were	NULL
cultured	NULL
at	NULL
1.5	NULL
X	NULL
10	NULL
%	NULL
60-mm	NULL
dishes	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
with	NULL
IFN-y	NULL
as	NULL
indicated	NULL
for	NULL
40	NULL
h	NULL
before	NULL
harvest	NULL
.	NULL

The	NULL
preparation	NULL
of	NULL
total	NULL
RNA	NULL
was	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
20992	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Effect	NULL
of	NULL
IFN-y	NULL
on	NULL
the	NULL
A	NULL
ACAT-1	NULL
gene	NULL
expression	NULL
during	NULL
the	NULL
human	NULL
blood	NULL
monocyte-macrophage	NULL
differentiation	NULL
process	NULL
.	NULL

Human	NULL
blood	NULL
monocytes	NULL
were	NULL
cultured	NULL
at	NULL
1.5	NULL
x	NULL
10	NULL
%	NULL
60-mm	NULL
dish	NULL
for	NULL
various	NULL
days	NULL
as	NULL
indicated	NULL
and	NULL
then	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
IFN-y	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
for	NULL
40	NULL
h	NULL
before	NULL
harvested	NULL
for	NULL
preparation	NULL
of	NULL
total	NULL
RNA	NULL
and	NULL
protein	NULL
extract	NULL
.	NULL

A	NULL
and	NULL
B	NULL
,	NULL
quantitation	NULL
by	NULL
RT-PCR	NULL
(	NULL
26	NULL
to	NULL
32	NULL
cycles	NULL
)	NULL
.	NULL

Appropriate	NULL
primers	NULL
de-	NULL
GAPDH	NULL
4.0	NULL
|-scribed	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
``	NULL
were	NULL
used	NULL
to	NULL
obtain	NULL
the	NULL
ACAT-1	NULL
P1	NULL
pro-	NULL
é	NULL
|	NULL
:	NULL
moter	NULL
transcript	NULL
(	NULL
designated	NULL
as	NULL
the	NULL
P1	NULL
(	NULL
330	NULL
product	NULL
)	NULL
,	NULL
the	NULL
ACAT-1	NULL
P7	NULL
promoter	NULL
tran-	NULL
3	NULL
script	NULL
(	NULL
designated	NULL
as	NULL
P7	NULL
product	NULL
)	NULL
,	NULL
and	NULL
the	NULL
.92.0|-transcript	NULL
for	NULL
the	NULL
control	NULL
gene	NULL
(	NULL
indicated	NULL
a	NULL
as	NULL
GAPDH	NULL
)	NULL
by	NULL
RT-PCR	NULL
.	NULL

Control	NULL
experi-	NULL
m	NULL
1.0	NULL
ments	NULL
indicated	NULL
that	NULL
between	NULL
cycles	NULL
25	NULL
and	NULL
35	NULL
,	NULL
the	NULL
ACAT-1	NULL
P1	NULL
transcript	NULL
and	NULL
the	NULL
ACAT-1	NULL
P7	NULL
transcript	NULL
could	NULL
be	NULL
estimated	NULL
0	NULL
semiquantitatively	NULL
by	NULL
RT-PCR	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
ratio	NULL
of	NULL
DNA	NULL
contents	NULL
(	NULL
shown	NULL
at	NULL
the	NULL
bottom	NULL
panels	NULL
)	NULL
was	NULL
determined	NULL
by	NULL
using	NULL
the	NULL
UVP	NULL
Labwork	NULL
soft-	NULL
C	NULL
ware	NULL
(	NULL
UVP	NULL
Inc.	NULL
)	NULL
.	NULL

C	NULL
,	NULL
immunoblotting	NULL
of	NULL
ACAT-1	NULL
protein	NULL
from	NULL
extracts	NULL
of	NULL
blood	NULL
monocyte-derived	NULL
macrophages	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
IFN-y	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
for	NULL
40	NULL
h.	NULL
Protein	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
immunoblotting	NULL
were	NULL
conducted	NULL
as	NULL
de-	NULL
scribed	NULL
under	NULL
``	NULL
Experimental	NULL
Proce-	NULL
dures	NULL
.	NULL
``	NULL

Samples	NULL
used	NULL
(	NULL
40	NULL
ug	NULL
of	NULL
protein/	NULL
lane	NULL
)	NULL
were	NULL
freshly	NULL
prepared	NULL
with	NULL
SDS	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
incubated	NULL
with	NULL
DM10	NULL
(	NULL
0.5	NULL
ug/ml	NULL
)	NULL
as	NULL
the	NULL
primary	NULL
antibody	NULL
.	NULL

The	NULL
immunoreactive	NULL
proteins	NULL
were	NULL
visualized	NULL
using	NULL
the	NULL
ECL	NULL
detection	NULL
system	NULL
and	NULL
au	NULL
toradiography	NULL
.	NULL

The	NULL
intensities	NULL
of	NULL
bands	NULL
were	NULL
determined	NULL
by	NULL
using	NULL
the	NULL
UVP	NULL
Lab	NULL
work	NULL
software	NULL
(	NULL
UVP	NULL
Inc.	NULL
)	NULL
.	NULL

The	NULL
data	NULL
are	NULL
expressed	NULL
as	NULL
relative	NULL
ACAT-1	NULL
protein	NULL
level	NULL
using	NULL
the	NULL
value	NULL
in	NULL
untreated	NULL
cells	NULL
as	NULL
1.0	NULL
.	NULL

The	NULL
ratios	NULL
of	NULL
the	NULL
ACAT-1	NULL
protein	NULL
from	NULL
treated	NULL
or	NULL
untreated	NULL
cells	NULL
were	NULL
shown	NULL
at	NULL
the	NULL
bottom	NULL
panel	NULL
.	NULL

according	NULL
to	NULL
the	NULL
single	NULL
step	NULL
acid	NULL
guanidinium	NULL
thiocyanate	NULL
phenol	NULL
chloroform	NULL
method	NULL
(	NULL
Trizol	NULL
Regent	NULL
,	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

Total	NULL
RNA	NULL
,	NULL
20	NULL
ug/	NULL
sample	NULL
,	NULL
were	NULL
electrophoresed	NULL
in	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
containing	NULL
2.2	NULL
M	NULL
formaldehyde	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
Nytran	NULL
membrane	NULL
(	NULL
Schleicher	NULL
and	NULL
Schuell	NULL
,	NULL
Dassel	NULL
,	NULL
Germany	NULL
)	NULL
with	NULL
3.0	NULL
M	NULL
sodium	NULL
chloride	NULL
,	NULL
0.3	NULL
M	NULL
sodium	NULL
citrate	NULL
(	NULL
20	NULL
X	NULL
SSC	NULL
)	NULL
as	NULL
the	NULL
transfer	NULL
buffer	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
cross-linked	NULL
by	NULL
UV	NULL
irradiation	NULL
and	NULL
incubated	NULL
for	NULL
10	NULL
min	NULL
at	NULL
65	NULL
°C	NULL
in	NULL
0.5	NULL
M	NULL
sodium	NULL
phosphate	NULL
buffer	NULL
(	NULL
pH	NULL
7.2	NULL
)	NULL
,	NULL
7	NULL
%	NULL
SDS	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
(	NULL
prehybridization	NULL
buffer	NULL
)	NULL
.	NULL

The	NULL
polymerase	NULL
chain	NULL
reaction	NULL
products	NULL
of	NULL
human	NULL
ACAT-1	NULL
cDNA	NULL
(	NULL
1486-2686	NULL
,	NULL
1.2-kilobases	NULL
)	NULL
and	NULL
human	NULL
GAPDH	NULL
cDNA	NULL
(	NULL
291-bp	NULL
)	NULL
were	NULL
used	NULL
as	NULL
templates	NULL
for	NULL
labeling	NULL
probes	NULL
.	NULL

Labeled	NULL
probes	NULL
were	NULL
made	NULL
with	NULL
[	NULL
a-*	NULL
``	NULL
PIdATP	NULL
by	NULL
the	NULL
random	NULL
primer	NULL
method	NULL
using	NULL
a	NULL
Random-labeling	NULL
Kit	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Blots	NULL
were	NULL
prehybridized	NULL
and	NULL
hybridized	NULL
with	NULL
labeled	NULL
probes	NULL
and	NULL
washed	NULL
under	NULL
high	NULL
stringency	NULL
conditions	NULL
.	NULL

Hybridization	NULL
was	NULL
carried	NULL
out	NULL
at	NULL
65	NULL
°C	NULL
in	NULL
the	NULL
same	NULL
solution	NULL
as	NULL
prehybridization	NULL
,	NULL
except	NULL
for	NULL
the	NULL
addition	NULL
of	NULL
labeled	NULL
probe	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
washed	NULL
with	NULL
40	NULL
mM	NULL
sodium	NULL
phosphate	NULL
buffer	NULL
(	NULL
pH	NULL
7.2	NULL
)	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
5	NULL
min	NULL
three	NULL
times	NULL
,	NULL
and	NULL
at	NULL
65°C	NULL
for	NULL
20	NULL
min	NULL
.	NULL

After	NULL
washing	NULL
,	NULL
the	NULL
membrane	NULL
was	NULL
exposed	NULL
and	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
bands	NULL
was	NULL
quantified	NULL
by	NULL
densitometric	NULL
analysis	NULL
using	NULL
the	NULL
UVP	NULL
Labwork	NULL
software	NULL
(	NULL
UVP	NULL
Inc.	NULL
)	NULL
.	NULL

To	NULL
serve	NULL
as	NULL
control	NULL
,	NULL
rehybridization	NULL
of	NULL
the	NULL
same	NULL
blot	NULL
with	NULL
the	NULL
human	NULL
GAPDH	NULL
probe	NULL
was	NULL
carried	NULL
out	NULL
.	NULL

The	NULL
sample	NULL
mRNA	NULL
expression	NULL
levels	NULL
were	NULL
normalized	NULL
by	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
human	NULL
GAPDH	NULL
mRNA	NULL
bands	NULL
.	NULL

Western	NULL
Blot	NULL
Analysis-Cells	NULL
were	NULL
harvested	NULL
with	NULL
10	NULL
%	NULL
SDS	NULL
in	NULL
50	NULL
mM	NULL
Tris	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
with	NULL
25	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
and	NULL
incubated	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
20	NULL
min	NULL
,	NULL
then	NULL
sheared	NULL
with	NULL
a	NULL
syringe	NULL
fitted	NULL
with	NULL
an	NULL
18-gauge	NULL
needle	NULL
.	NULL

Protein	NULL
concentration	NULL
of	NULL
the	NULL
cell	NULL
extract	NULL
was	NULL
determined	NULL
by	NULL
a	NULL
modified	NULL
Lowry	NULL
method	NULL
(	NULL
84	NULL
)	NULL
.	NULL

The	NULL
affinity	NULL
purified	NULL
anti-ACAT-1	NULL
IgGs	NULL
(	NULL
designated	NULL
as	NULL
DM10	NULL
)	NULL
was	NULL
used	NULL
as	NULL
the	NULL
primary	NULL
antibodies	NULL
against	NULL
ACAT-1	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Western	NULL
blots	NULL
,	NULL
using	NULL
freshly	NULL
prepared	NULL
cell	NULL
extracts	NULL
in	NULL
SDS	NULL
,	NULL
were	NULL
conducted	NULL
according	NULL
to	NULL
a	NULL
previously	NULL
described	NULL
procedure	NULL
(	NULL
85	NULL
)	NULL
.	NULL

ACAT	NULL
Activity	NULL
Assay-The	NULL
assay	NULL
was	NULL
performed	NULL
essentially	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
15	NULL
,	NULL
35	NULL
)	NULL
.	NULL

AC29	NULL
,	NULL
25RA	NULL
,	NULL
and	NULL
THP-1	NULL
cells	NULL
were	NULL
cultured	NULL
erproduct	NULL
=	NULL
l	NULL
o	NULL
i	NULL
i	NULL
u	NULL
i	NULL
ti	NULL
a	NULL
cnd	NULL
Activation	NULL
of	NULL
ACAT-1	NULL
by	NULL
IFN-y	NULL
in	NULL
Foam	NULL
Cell	NULL
Formation	NULL
B	NULL
P7	NULL
product	NULL
GAPDH	NULL
Ratio	NULL
of	NULL
DNA	NULL
2	NULL
to-	NULL
40-40	NULL
-+	NULL
Ratio	NULL
of	NULL
protein	NULL
DE	NULL
}	NULL
;	NULL
0	NULL
IFN-y	NULL
_	NULL
-	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
ba	NULL
bo	NULL
42	NULL
4	NULL
go	NULL
co	NULL
a	NULL
a	NULL
at	NULL
2	NULL
X	NULL
10°/ml	NULL
in	NULL
60-mm	NULL
dishes	NULL
and	NULL
then	NULL
treated	NULL
in	NULL
various	NULL
manners	NULL
for	NULL
40	NULL
h	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
ACAT-l-deficient	NULL
mutant	NULL
cell	NULL
line	NULL
AC29	NULL
,	NULL
and	NULL
its	NULL
parental	NULL
cell	NULL
25RA	NULL
derived	NULL
from	NULL
Chinese	NULL
hamster	NULL
ovary	NULL
cells	NULL
(	NULL
2	NULL
,	NULL
15	NULL
,	NULL
35	NULL
)	NULL
were	NULL
used	NULL
to	NULL
ensure	NULL
that	NULL
the	NULL
ACAT	NULL
activity	NULL
assayed	NULL
in	NULL
vitro	NULL
work	NULL
properly	NULL
.	NULL

For	NULL
THP-1	NULL
cells	NULL
,	NULL
the	NULL
suspended	NULL
and	NULL
adherent	NULL
cells	NULL
were	NULL
collected	NULL
by	NULL
direct	NULL
centrifugation	NULL
and	NULL
scrapping	NULL
,	NULL
respectively	NULL
,	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
two	NULL
groups	NULL
of	NULL
cells	NULL
collected	NULL
from	NULL
the	NULL
same	NULL
dish	NULL
were	NULL
pooled	NULL
together	NULL
,	NULL
washed	NULL
with	NULL
PBS	NULL
once	NULL
,	NULL
and	NULL
centrifuged	NULL
to	NULL
collect	NULL
the	NULL
cell	NULL
pellets	NULL
.	NULL

Cold	NULL
1	NULL
mM	NULL
Tris	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
(	NULL
pH	NULL
7.8	NULL
)	NULL
,	NULL
at	NULL
100	NULL
ul/sample	NULL
,	NULL
was	NULL
added	NULL
to	NULL
cell	NULL
pellet	NULL
chilled	NULL
on	NULL
ice	NULL
.	NULL

The	NULL
mixtures	NULL
were	NULL
left	NULL
on	NULL
ice	NULL
for	NULL
5	NULL
min	NULL
.	NULL

Brief	NULL
but	NULL
vigorous	NULL
vortexing	NULL
(	NULL
30	NULL
s	NULL
to	NULL
1	NULL
min	NULL
)	NULL
was	NULL
used	NULL
to	NULL
cause	NULL
extensive	NULL
cell	NULL
lysis	NULL
.	NULL

The	NULL
protein	NULL
concentration	NULL
of	NULL
the	NULL
cell	NULL
homogenates	NULL
was	NULL
kept	NULL
at	NULL
2-4	NULL
mg/ml	NULL
in	NULL
buffer	NULL
A	NULL
(	NULL
50	NULL
mM	NULL
Tris	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
at	NULL
pH	NULL
7.8	NULL
with	NULL
protease	NULL
inhibitors	NULL
)	NULL
.	NULL

The	NULL
enzyme	NULL
was	NULL
solubilized	NULL
and	NULL
assayed	NULL
in	NULL
mixed	NULL
micelle	NULL
condition	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
85	NULL
)	NULL
.	NULL

RESULTS	NULL
A	NULL
159-bp	NULL
Core	NULL
Region	NULL
with	NULL
4	NULL
Sp1	NULL
Elements	NULL
Is	NULL
Responsible	NULL
for	NULL
Human	NULL
ACAT-1	NULL
P1	NULL
Promoter	NULL
Activity-Human	NULL
ACAT-1	NULL
gene	NULL
is	NULL
located	NULL
in	NULL
two	NULL
different	NULL
chromosomes	NULL
(	NULL
1	NULL
and	NULL
7	NULL
)	NULL
,	NULL
each	NULL
chromosome	NULL
containing	NULL
a	NULL
separate	NULL
ACAT-1	NULL
promoter	NULL
(	NULL
Pl	NULL
and	NULL
P7	NULL
)	NULL
.	NULL

Northern	NULL
analyses	NULL
have	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
four	NULL
ACAT-1	NULL
mRNAs	NULL
(	NULL
7.0	NULL
,	NULL
4.3	NULL
,	NULL
3.6	NULL
,	NULL
and	NULL
2.8-knt	NULL
)	NULL
in	NULL
all	NULL
the	NULL
human	NULL
tissues	NULL
and	NULL
cell	NULL
lines	NULL
examined	NULL
(	NULL
3	NULL
)	NULL
.	NULL

The	NULL
2.8	NULL
and	NULL
3.6-knt	NULL
messages	NULL
are	NULL
produced	NULL
from	NULL
the	NULL
P1	NULL
promoter	NULL
,	NULL
while	NULL
the	NULL
4.3-knt	NULL
mRNA	NULL
is	NULL
produced	NULL
from	NULL
two	NULL
different	NULL
chromosomes	NULL
by	NULL
a	NULL
novel	NULL
RNA	NULL
recombination	NULL
event	NULL
that	NULL
presumably	NULL
involves	NULL
trans-splicing	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
P1	NULL
promoter	NULL
is	NULL
contiguous	NULL
with	NULL
the	NULL
coding	NULL
sequence	NULL
and	NULL
spans	NULL
from	NULL
-598	NULL
to	NULL
+65	NULL
of	NULL
the	NULL
ACAT-1	NULL
genomic	NULL
DNA	NULL
(	NULL
26	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
minimal	NULL
region	NULL
of	NULL
the	NULL
P1	NULL
promoter	NULL
,	NULL
we	NULL
trans-	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Activation	NULL
of	NULL
ACAT-1	NULL
by	NULL
IFN-y	NULL
in	NULL
Foam	NULL
Cell	NULL
Formation	NULL
A	NULL
4	NULL
5	NULL
2	NULL
3|-8	NULL
2	NULL
}	NULL
8	NULL
Eh	NULL
_|—|	NULL
“	NULL
I	NULL
T	NULL
2	NULL
u	NULL
0	NULL
+	NULL
-o	NULL
&	NULL
-	NULL
+	NULL
-o	NULL
£0	NULL
IFN-y	NULL
ai	NULL
«	NULL
4	NULL
3	NULL
ATRA	NULL
mos	NULL
$	NULL
>	NULL
%	NULL
moe	NULL
oz	NULL
wo	NULL
as	NULL
up	NULL
of	NULL
P	NULL
]	NULL
P	NULL
?	NULL

PNY-III	NULL
B	NULL
4	NULL
t	NULL
o	NULL
.	NULL

!	NULL

_	NULL
WD	NULL
On	NULL
(	NULL
N	NULL
!	NULL

aa	NULL
Relative	NULL
luciferase	NULL
activity	NULL
(	NULL
fold	NULL
)	NULL
IFN-y	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
%	NULL
-	NULL
%	NULL
+o	NULL
-	NULL
+	NULL
ATRA	NULL
~	NULL
~	NULL
+	NULL
%	NULL
=	NULL
=	NULL
+	NULL
+	NULL
~~~	NULL
+	NULL
+	NULL
-o-	NULL
4+	NULL
0+	NULL
-=	NULL
$	NULL
4	NULL
HEK293	NULL
HepG2	NULL
CaCo-2	NULL
u937	NULL
THP-1	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

The	NULL
synergistic	NULL
effect	NULL
of	NULL
IFN-y	NULL
and	NULL
ATRA	NULL
on	NULL
ACAT	NULL
P1	NULL
promoter	NULL
is	NULL
promoter	NULL
specific	NULL
and	NULL
cell	NULL
type	NULL
specific	NULL
.	NULL

A	NULL
,	NULL
the	NULL
Lus	NULL
constructs	NULL
containing	NULL
ACAT-1	NULL
P1	NULL
,	NULL
or	NULL
P7	NULL
,	NULL
or	NULL
the	NULL
SV40	NULL
promoters	NULL
ligated	NULL
to	NULL
the	NULL
luciferase	NULL
reporter	NULL
vector	NULL
(	NULL
pGL2-C	NULL
)	NULL
were	NULL
transfected	NULL
into	NULL
THP-1	NULL
cells	NULL
.	NULL

7	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
IFN-y	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
,	NULL
or	NULL
with	NULL
ATRA	NULL
(	NULL
10~°	NULL
M	NULL
)	NULL
or	NULL
IFN-y	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
plus	NULL
ATRA	NULL
(	NULL
10~°	NULL
M	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
luciferase	NULL
activity	NULL
was	NULL
determined	NULL
in	NULL
lysates	NULL
of	NULL
THP-1	NULL
cells	NULL
40	NULL
h	NULL
later	NULL
,	NULL
and	NULL
normalized	NULL
by	NULL
using	NULL
values	NULL
of	NULL
-galactosidase	NULL
.	NULL

The	NULL
data	NULL
were	NULL
expressed	NULL
as	NULL
luciferase	NULL
activities	NULL
relative	NULL
to	NULL
the	NULL
value	NULL
from	NULL
untreated	NULL
cells	NULL
as	NULL
one	NULL
.	NULL

Values	NULL
represented	NULL
the	NULL
means	NULL
from	NULL
triplicate	NULL
determinations	NULL
.	NULL

Sizes	NULL
of	NULL
error	NULL
bars	NULL
represented	NULL
1	NULL
S.E	NULL
.	NULL

B	NULL
,	NULL
the	NULL
Luc	NULL
construct	NULL
containing	NULL
ACAT-1	NULL
P1	NULL
promoter	NULL
was	NULL
transfected	NULL
into	NULL
THP-1	NULL
,	NULL
U937	NULL
,	NULL
HepG2	NULL
,	NULL
Caco-2	NULL
,	NULL
or	NULL
HEK298	NULL
cells	NULL
as	NULL
indicated	NULL
by	NULL
methods	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
treated	NULL
and	NULL
assayed	NULL
as	NULL
described	NULL
in	NULL
A.	NULL
fected	NULL
THP-1	NULL
cells	NULL
with	NULL
constructs	NULL
containing	NULL
various	NULL
deleted	NULL
fragments	NULL
fused	NULL
upstream	NULL
to	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
of	NULL
the	NULL
pGL2-enhancer	NULL
vector	NULL
(	NULL
pGL2-E	NULL
)	NULL
,	NULL
and	NULL
measured	NULL
luciferase	NULL
activities	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
the	NULL
right	NULL
panel	NULL
!	NULL

of	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
the	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
maximal	NULL
transcriptional	NULL
activity	NULL
is	NULL
located	NULL
within	NULL
the	NULL
159-base	NULL
pair	NULL
from	NULL
-125	NULL
to	NULL
+34	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

Sequence	NULL
analysis	NULL
by	NULL
computer	NULL
revealed	NULL
4	NULL
Spl	NULL
elements	NULL
are	NULL
located	NULL
in	NULL
this	NULL
core	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

We	NULL
next	NULL
performed	NULL
various	NULL
specific	NULL
deletion	NULL
analyses	NULL
to	NULL
test	NULL
the	NULL
relative	NULL
importance	NULL
of	NULL
these	NULL
4	NULL
Spl	NULL
elements	NULL
.	NULL

The	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
showed	NULL
that	NULL
the	NULL
most	NULL
important	NULL
basal	NULL
transcription	NULL
activity	NULL
is	NULL
present	NULL
in	NULL
the	NULL
first	NULL
two	NULL
Spl	NULL
elements	NULL
from	NULL
the	NULL
5'-end	NULL
of	NULL
the	NULL
159-bp	NULL
core	NULL
region	NULL
.	NULL

To	NULL
demonstrate	NULL
the	NULL
functional	NULL
importance	NULL
of	NULL
the	NULL
4	NULL
Spl	NULL
elements	NULL
involved	NULL
in	NULL
basal	NULL
transcription	NULL
,	NULL
we	NULL
next	NULL
performed	NULL
EMSA	NULL
.	NULL

We	NULL
used	NULL
nuclear	NULL
extracts	NULL
of	NULL
THP-1	NULL
cells	NULL
and	NULL
the	NULL
159-bp	NULL
DNA	NULL
fragments	NULL
containing	NULL
mutations	NULL
in	NULL
each	NULL
of	NULL
all	NULL
the	NULL
4	NULL
Spl	NULL
elements	NULL
as	NULL
labeled	NULL
probes	NULL
.	NULL

The	NULL
bindings	NULL
of	NULL
labeled	NULL
probes	NULL
were	NULL
tested	NULL
by	NULL
competing	NULL
with	NULL
unlabeled	NULL
wild-type	NULL
or	NULL
mutated	NULL
probes	NULL
in	NULL
100-fold	NULL
molar	NULL
excess	NULL
.	NULL

The	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
illustrated	NULL
that	NULL
the	NULL
wild-type	NULL
DNA	NULL
fragment	NULL
formed	NULL
several	NULL
DNA-protein	NULL
complexes	NULL
(	NULL
Zanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
5	NULL
)	NULL
;	NULL
the	NULL
bindings	NULL
were	NULL
eliminated	NULL
upon	NULL
incubation	NULL
with	NULL
excess	NULL
unlabeled	NULL
probe	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
and	NULL
20993	NULL
J	NULL
»	NULL
Relative	NULL
luciferase	NULL
activity	NULL
(	NULL
fold	NULL
)	NULL
0	NULL
:	NULL
P	NULL
R	NULL
500	NULL
1000	NULL
1500	NULL
2000	NULL
IFN-y	NULL
(	NULL
U/m1	NULL
)	NULL
a	NULL
6C	NULL
3	NULL
2	NULL
$	NULL
s-	NULL
>	NULL
.Z	NULL
§	NULL
4	NULL
}	NULL
&	NULL
©	NULL
w	NULL
§	NULL
3	NULL
2	NULL
'	NULL
3	NULL
3	NULL
2	NULL
}	NULL
9	NULL
Mu	NULL
s	NULL
1f	NULL
43	NULL
|	NULL
[	NULL
«	NULL
4	NULL
n	NULL
T	NULL
i	NULL
.	NULL

i	NULL
10®	NULL
10®	NULL
107	NULL
106	NULL
105	NULL
ATRA	NULL
-	NULL
(	NULL
M	NULL
)	NULL
7	NULL
|	NULL
o\	NULL
I	NULL
HH	NULL
Relative	NULL
luciferase	NULL
activity	NULL
(	NULL
fold	NULL
)	NULL
a	NULL
3	NULL
2	NULL
E	NULL
1	NULL
F	NULL
0	NULL
i	NULL
L	NULL
1	NULL
\	NULL
12	NULL
24	NULL
36	NULL
48	NULL
60	NULL
Time	NULL
(	NULL
hour	NULL
)	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

The	NULL
dose	NULL
and	NULL
time	NULL
dependence	NULL
of	NULL
the	NULL
IFN-y	NULL
and	NULL
ATRA	NULL
effects	NULL
.	NULL

The	NULL
Luc	NULL
constructs	NULL
containing	NULL
ACAT-1	NULL
P1	NULL
promoter	NULL
was	NULL
transfected	NULL
into	NULL
THP-1	NULL
cells	NULL
.	NULL

7	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
A	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
ATRA	NULL
(	NULL
10~°	NULL
M	NULL
)	NULL
alone	NULL
,	NULL
or	NULL
with	NULL
ATRA	NULL
plus	NULL
the	NULL
indicated	NULL
concentrations	NULL
of	NULL
IFN-y	NULL
,	NULL
respectively	NULL
,	NULL
for	NULL
40	NULL
h	NULL
;	NULL
B	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
IFN-y	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
alone	NULL
,	NULL
or	NULL
with	NULL
IFN-y	NULL
plus	NULL
indicated	NULL
concentrations	NULL
of	NULL
ATRA	NULL
for	NULL
40	NULL
h	NULL
;	NULL
C	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
ATRA	NULL
(	NULL
10°	NULL
M	NULL
)	NULL
plus	NULL
IFN-y	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
lengths	NULL
of	NULL
time	NULL
,	NULL
respectively	NULL
.	NULL

Afterward	NULL
,	NULL
the	NULL
luciferase	NULL
activity	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

supershifted	NULL
by	NULL
incubation	NULL
with	NULL
the	NULL
anti-Spl	NULL
antibodies	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
.	NULL

Additional	NULL
control	NULL
experiments	NULL
showed	NULL
that	NULL
the	NULL
fragment	NULL
containing	NULL
mutations	NULL
in	NULL
all	NULL
4	NULL
Spl	NULL
elements	NULL
had	NULL
no	NULL
specific	NULL
binding	NULL
(	NULL
Zanes	NULL
7-10	NULL
)	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
20994	NULL
FiG	NULL
.	NULL

6	NULL
.	NULL

IFN-y	NULL
and	NULL
ATRA	NULL
symergisti-	NULL
A	NULL
cally	NULL
increase	NULL
ACAT-1	NULL
mRNA	NULL
.	NULL

Total	NULL
RNAs	NULL
were	NULL
prepared	NULL
from	NULL
THP-1	NULL
cells	NULL
treated	NULL
for	NULL
40	NULL
h	NULL
with	NULL
or	NULL
without	NULL
IFN-y	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
,	NULL
or	NULL
with	NULL
ATRA	NULL
(	NULL
10~°	NULL
M	NULL
)	NULL
or	NULL
with	NULL
IFN-y	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
plus	NULL
ATRA	NULL
(	NULL
10~	NULL
``	NULL
M	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

A	NULL
and	NULL
B	NULL
,	NULL
quantita-	NULL
GAPDH	NULL
tion	NULL
by	NULL
RT-PCR	NULL
(	NULL
26	NULL
to	NULL
32	NULL
cycles	NULL
)	NULL
.	NULL

Appro-	NULL
20	NULL
priate	NULL
primers	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
``	NULL
were	NULL
used	NULL
to	NULL
obtain	NULL
the	NULL
ACAT-1	NULL
P1	NULL
promoter	NULL
transcript	NULL
(	NULL
designated	NULL
as	NULL
the	NULL
P1	NULL
product	NULL
)	NULL
,	NULL
the	NULL
ACAT-1	NULL
P7	NULL
promoter	NULL
transcript	NULL
(	NULL
designated	NULL
as	NULL
P7	NULL
product	NULL
)	NULL
,	NULL
and	NULL
the	NULL
transcript	NULL
for	NULL
the	NULL
control	NULL
gene	NULL
(	NULL
indicated	NULL
as	NULL
GAPDH	NULL
)	NULL
by	NULL
RT-PCR	NULL
.	NULL

Control	NULL
experiments	NULL
indicated	NULL
that	NULL
between	NULL
cycles	NULL
25	NULL
and	NULL
35	NULL
,	NULL
the	NULL
ACAT-1	NULL
P1	NULL
0	NULL
transcript	NULL
and	NULL
the	NULL
ACAT-1	NULL
P7	NULL
transcript	NULL
IFN-y	NULL
could	NULL
be	NULL
estimated	NULL
semiquantitatively	NULL
by	NULL
ATRA	NULL
RT-PCR	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
ratio	NULL
of	NULL
DNA	NULL
contents	NULL
(	NULL
shown	NULL
at	NULL
the	NULL
bottom	NULL
panels	NULL
)	NULL
was	NULL
determined	NULL
using	NULL
the	NULL
UVP	NULL
Lab-	NULL
C	NULL
work	NULL
software	NULL
(	NULL
UVP	NULL
Inc.	NULL
)	NULL
.	NULL

C	NULL
,	NULL
quantitation	NULL
by	NULL
Northern	NULL
analysis	NULL
.	NULL

20	NULL
ug	NULL
of	NULL
total	NULL
RNAs	NULL
per	NULL
lane	NULL
from	NULL
cells	NULL
treated	NULL
in	NULL
various	NULL
Ratio	NULL
of	NULL
DNA	NULL
_	NULL
Activation	NULL
of	NULL
ACAT-1	NULL
by	NULL
IFN-y	NULL
in	NULL
Foam	NULL
Cell	NULL
Formation	NULL
B	NULL
0.8	NULL
0.6	NULL
0.4	NULL
Ratio	NULL
of	NULL
DNA	NULL
0.2	NULL
0	NULL
~	NULL
*+	NULL
~	NULL
+	NULL
IFN-y	NULL
_	NULL
-	NULL
+	NULL
=-	NULL
+	NULL
-	NULL
-	NULL
*	NULL
*+	NULL
ATRA	NULL
|	NULL
-	NULL
=	NULL
+	NULL
+	NULL
manners	NULL
as	NULL
indicated	NULL
was	NULL
employed	NULL
,	NULL
using	NULL
a	NULL
*°P-labeled	NULL
ACAT-1	NULL
cDNA	NULL
probe	NULL
;	NULL
the	NULL
same	NULL
filter	NULL
was	NULL
rehybridized	NULL
with	NULL
a	NULL
*°P-labeled	NULL
human	NULL
GAPDH	NULL
cDNA	NULL
probe	NULL
.	NULL

After	NULL
exposing	NULL
with	NULL
PhosphorImager	NULL
,	NULL
the	NULL
intensities	NULL
of	NULL
the	NULL
2.8-	NULL
and	NULL
3.6-knt	NULL
ACAT-1	NULL
R.	NULL
3.6	NULL
knt-	NULL
»	NULL
|	NULL
|	NULL
2.8	NULL
|x	NULL
}	NULL
were	NULL
normalized	NULL
to	NULL
that	NULL
of	NULL
the	NULL
GAPDH	NULL
mRNA	NULL
levels	NULL
;	NULL
the	NULL
intensities	NULL
of	NULL
bands	NULL
were	NULL
determined	NULL
by	NULL
using	NULL
the	NULL
UVP	NULL
Lab	NULL
GAPDH~*	NULL
Ratio	NULL
of	NULL
RNA	NULL
o	NULL
o	NULL
in	NULL
work	NULL
software	NULL
(	NULL
UVP	NULL
Inc.	NULL
)	NULL
.	NULL

The	NULL
ratios	NULL
of	NULL
the	NULL
2.8-	NULL
and	NULL
3.6-knt	NULL
message	NULL
from	NULL
cells	NULL
IFN-y	NULL
treated	NULL
in	NULL
various	NULL
manners	NULL
as	NULL
indicated	NULL
ATRA	NULL
were	NULL
shown	NULL
on	NULL
the	NULL
right	NULL
panel	NULL
.	NULL

Interferon-y	NULL
Causes	NULL
up-regulation	NULL
of	NULL
Human	NULL
ACAT	NULL
Expression	NULL
in	NULL
Blood	NULL
Monocyte-derived	NULL
Macrophages-The	NULL
human	NULL
blood	NULL
monocytes	NULL
were	NULL
incubated	NULL
in	NULL
culture	NULL
for	NULL
up	NULL
to	NULL
16	NULL
days	NULL
.	NULL

This	NULL
procedure	NULL
causes	NULL
monocytic	NULL
cells	NULL
to	NULL
differentiate	NULL
into	NULL
mature	NULL
macrophages	NULL
within	NULL
several	NULL
days	NULL
.	NULL

Cells	NULL
incubated	NULL
for	NULL
various	NULL
time	NULL
points	NULL
were	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
IFN-y	NULL
for	NULL
40	NULL
h.	NULL
The	NULL
total	NULL
RNAs	NULL
and	NULL
proteins	NULL
of	NULL
treated	NULL
and	NULL
untreated	NULL
cells	NULL
were	NULL
extracted	NULL
for	NULL
RT-PCR	NULL
and	NULL
Western	NULL
blot	NULL
.	NULL

The	NULL
results	NULL
show	NULL
that	NULL
both	NULL
the	NULL
ACAT-I	NULL
P1	NULL
promoter	NULL
transcript	NULL
and	NULL
the	NULL
ACAT-1	NULL
protein	NULL
level	NULL
increased	NULL
during	NULL
the	NULL
monocyte	NULL
differentiation	NULL
process	NULL
;	NULL
and	NULL
these	NULL
increases	NULL
were	NULL
further	NULL
augmented	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
IFN-y	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
A	NULL
and	NULL
C	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
level	NULL
of	NULL
the	NULL
human	NULL
ACAT-1	NULL
P7	NULL
promoter	NULL
transcript	NULL
was	NULL
not	NULL
significantly	NULL
altered	NULL
throughout	NULL
the	NULL
time	NULL
course	NULL
of	NULL
the	NULL
experiment	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

The	NULL
Combination	NULL
of	NULL
IFN-y	NULL
and	NULL
ATRA	NULL
Is	NULL
Needed	NULL
to	NULL
Enhance	NULL
ACAT-1	NULL
P1	NULL
Promoter	NULL
Activity	NULL
in	NULL
THP-1	NULL
Cell-Using	NULL
THP-1	NULL
cell	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
functional	NULL
responses	NULL
of	NULL
the	NULL
ACAT-1	NULL
P1	NULL
promoter	NULL
toward	NULL
IFN-y	NULL
,	NULL
ATRA	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
both	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
treating	NULL
cells	NULL
with	NULL
IFN-y	NULL
and	NULL
ATRA	NULL
,	NULL
but	NULL
not	NULL
with	NULL
IFN-y	NULL
or	NULL
with	NULL
ATRA	NULL
alone	NULL
,	NULL
synergistically	NULL
enhanced	NULL
the	NULL
luciferase	NULL
expression	NULL
driven	NULL
by	NULL
the	NULL
ACAT-1	NULL
P1	NULL
promoter	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
cell	NULL
type	NULL
and	NULL
promoter	NULL
specificity	NULL
of	NULL
this	NULL
effect	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
human	NULL
ACAT-1	NULL
P1	NULL
,	NULL
P7	NULL
,	NULL
and	NULL
SV40	NULL
promoters	NULL
in	NULL
THP-1	NULL
cells	NULL
,	NULL
using	NULL
the	NULL
luciferase	NULL
reporter	NULL
activity	NULL
assays	NULL
.	NULL

The	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
showed	NULL
that	NULL
neither	NULL
IFN-y	NULL
,	NULL
ATRA	NULL
,	NULL
nor	NULL
their	NULL
combination	NULL
,	NULL
had	NULL
any	NULL
detectable	NULL
effect	NULL
on	NULL
the	NULL
ACAT-1	NULL
P7	NULL
or	NULL
the	NULL
SV40	NULL
promoter	NULL
.	NULL

We	NULL
also	NULL
tested	NULL
the	NULL
potential	NULL
effect	NULL
of	NULL
ATRA	NULL
and/or	NULL
IFN-y	NULL
on	NULL
ACAT-1	NULL
P1	NULL
promoter	NULL
in	NULL
other	NULL
human	NULL
cell	NULL
lines	NULL
including	NULL
HEK293	NULL
,	NULL
HepG2	NULL
,	NULL
CaCO-2	NULL
,	NULL
and	NULL
U937	NULL
.	NULL

The	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
demonstrated	NULL
that	NULL
the	NULL
synergistic	NULL
effect	NULL
of	NULL
ATRA	NULL
and	NULL
IFN-y	NULL
occurred	NULL
only	NULL
in	NULL
the	NULL
monocytic	NULL
cell	NULL
lines	NULL
(	NULL
eg	NULL
.	NULL

U937	NULL
,	NULL
THP-1	NULL
)	NULL
,	NULL
but	NULL
not	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
(	NULL
eg	NULL
.	NULL

HEK293	NULL
,	NULL
HepG2	NULL
,	NULL
or	NULL
CACO-2	NULL
)	NULL
.	NULL

Using	NULL
THP	NULL
-1	NULL
cells	NULL
,	NULL
we	NULL
next	NULL
investigated	NULL
the	NULL
time	NULL
and	NULL
dose	NULL
requirements	NULL
.	NULL

For	NULL
IFN-y	NULL
,	NULL
the	NULL
results	NULL
showed	NULL
that	NULL
the	NULL
-	NULL
1.0	NULL
25	NULL
0.8	NULL
2.0	NULL
0.6	NULL
1.5	NULL
04	NULL
}	NULL
n	NULL
02	NULL
0°	NULL
0	NULL
=	NULL
+	NULL
=	NULL
+	NULL
aoe	NULL
es	NULL
ATRA	NULL
-	NULL
~10	NULL
%	NULL
(	NULL
%	NULL
n	NULL
-l	NULL
p	NULL
%	NULL
2.8	NULL
knt	NULL
3.6	NULL
knt	NULL
enhancement	NULL
exhibited	NULL
a	NULL
saturable	NULL
process	NULL
,	NULL
with	NULL
maximal	NULL
enhancement	NULL
seen	NULL
when	NULL
IFN-y	NULL
reached	NULL
500	NULL
units/ml	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
.	NULL

For	NULL
ATRA	NULL
,	NULL
a	NULL
non-saturable	NULL
,	NULL
linear	NULL
relationship	NULL
between	NULL
concentration	NULL
and	NULL
effect	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
IFN-y	NULL
and	NULL
ATRA	NULL
continued	NULL
to	NULL
increase	NULL
within	NULL
the	NULL
time	NULL
frame	NULL
examined	NULL
(	NULL
60	NULL
h	NULL
,	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

To	NULL
ascertain	NULL
that	NULL
the	NULL
activating	NULL
effect	NULL
of	NULL
ATRA/IFN-y	NULL
on	NULL
ACAT-1	NULL
promoter	NULL
bears	NULL
biological	NULL
relevance	NULL
,	NULL
we	NULL
treated	NULL
THP-1	NULL
cells	NULL
for	NULL
40	NULL
h	NULL
with	NULL
either	NULL
IFN-y	NULL
or	NULL
ATRA	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
both	NULL
,	NULL
then	NULL
examined	NULL
the	NULL
ACAT-1	NULL
at	NULL
the	NULL
levels	NULL
of	NULL
mRNAs	NULL
,	NULL
protein	NULL
,	NULL
and	NULL
enzyme	NULL
activities	NULL
.	NULL

Semiquantitative	NULL
RT-PCR	NULL
analysis	NULL
showed	NULL
that	NULL
the	NULL
level	NULL
of	NULL
human	NULL
ACAT-1	NULL
P1	NULL
promoter	NULL
transcripts	NULL
in	NULL
treated	NULL
cells	NULL
increased	NULL
by	NULL
about	NULL
3-fold	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
,	NULL
while	NULL
the	NULL
level	NULL
of	NULL
human	NULL
ACAT-1	NULL
P7	NULL
promoter	NULL
transcripts	NULL
were	NULL
not	NULL
significantly	NULL
altered	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
these	NULL
re-sults	NULL
,	NULL
Northern	NULL
blotting	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
showed	NULL
that	NULL
the	NULL
amounts	NULL
of	NULL
3.6-	NULL
and	NULL
2.8-knt	NULL
mRNAs	NULL
(	NULL
26	NULL
)	NULL
were	NULL
significantly	NULL
enhanced	NULL
by	NULL
the	NULL
combination	NULL
treatment	NULL
of	NULL
IFN-y	NULL
and	NULL
ATRA	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
ACAT-1	NULL
protein	NULL
as	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
by	NULL
the	NULL
ACAT	NULL
enzyme	NULL
activity	NULL
,	NULL
measured	NULL
in	NULL
cholesterol-independent	NULL
manner	NULL
,	NULL
was	NULL
all	NULL
significantly	NULL
and	NULL
proportionally	NULL
increased	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

IFN-y	NULL
Activated	NULL
Sequence	NULL
(	NULL
GAS	NULL
)	NULL
Is	NULL
Required	NULL
for	NULL
the	NULL
Synergistic	NULL
Effect	NULL
by	NULL
IFN-y	NULL
and	NULL
ATRA-Sequence	NULL
analysis	NULL
by	NULL
computer	NULL
showed	NULL
that	NULL
the	NULL
core	NULL
region	NULL
of	NULL
human	NULL
ACAT-1	NULL
P1	NULL
promoter	NULL
contained	NULL
an	NULL
GAS	NULL
that	NULL
overlaps	NULL
exactly	NULL
with	NULL
the	NULL
second	NULL
Spl	NULL
element	NULL
from	NULL
5'-end	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

To	NULL
test	NULL
its	NULL
functional	NULL
signif-icance	NULL
,	NULL
a	NULL
series	NULL
of	NULL
P1	NULL
promoter	NULL
deletion	NULL
and	NULL
point	NULL
mutation	NULL
constructs	NULL
were	NULL
made	NULL
,	NULL
linked	NULL
to	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
,	NULL
and	NULL
used	NULL
in	NULL
transient	NULL
transfection	NULL
studies	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
two	NULL
constructs	NULL
containing	NULL
the	NULL
GAS	NULL
element	NULL
(	NULL
at	NULL
the	NULL
top	NULL
of	NULL
Fig	NULL
.	NULL

84	NULL
)	NULL
responded	NULL
to	NULL
IFN-y	NULL
and	NULL
ATRA	NULL
,	NULL
while	NULL
the	NULL
shorter	NULL
promoter	NULL
lacking	NULL
the	NULL
GAS	NULL
element	NULL
and	NULL
first	NULL
two	NULL
Spl	NULL
elements	NULL
(	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
did	NULL
not	NULL
.	NULL

Specific	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Activation	NULL
of	NULL
ACAT-1	NULL
by	NULL
IFN-y	NULL
in	NULL
Foam	NULL
Cell	NULL
Formation	NULL
mutations	NULL
in	NULL
the	NULL
GAS	NULL
element	NULL
,	NULL
but	NULL
not	NULL
mutations	NULL
in	NULL
the	NULL
Spl	NULL
elements	NULL
,	NULL
abrogated	NULL
the	NULL
synergistic	NULL
effect	NULL
by	NULL
IFN-y	NULL
and	NULL
ATRA	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
GAS	NULL
element	NULL
,	NULL
rather	NULL
than	NULL
the	NULL
4	NULL
Spl	NULL
sites	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
mediating	NULL
the	NULL
regulatory	NULL
response	NULL
to	NULL
IFN-y	NULL
and	NULL
ATRA	NULL
.	NULL

To	NULL
further	NULL
examine	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
the	NULL
GAS	NULL
element	NULL
,	NULL
we	NULL
isolated	NULL
nuclear	NULL
extracts	NULL
from	NULL
THP-1	NULL
cells	NULL
co-treated	NULL
with	NULL
IFN-y	NULL
and	NULL
ATRA	NULL
,	NULL
and	NULL
performed	NULL
EMSA	NULL
using	NULL
the	NULL
wild-type	NULL
Pl	NULL
promoter	NULL
(	NULL
the	NULL
159-bp	NULL
DNA	NULL
)	NULL
as	NULL
the	NULL
labeled	NULL
probe	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
C	NULL
and	NULL
D	NULL
,	NULL
two	NULL
specific	NULL
bands	NULL
,	NULL
one	NULL
migrating	NULL
slower	NULL
than	NULL
the	NULL
other	NULL
,	NULL
were	NULL
detectable	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

These	NULL
two	NULL
bands	NULL
were	NULL
abolished	NULL
by	NULL
preincubation	NULL
with	NULL
unlabeled	NULL
competitors	NULL
containing	NULL
all	NULL
the	NULL
Spl	NULL
and	NULL
GAS	NULL
elements	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8C	NULL
,	NULL
gel	NULL
supershift	NULL
assays	NULL
using	NULL
either	NULL
anti-Spl	NULL
antibodies	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
or	NULL
anti-STAT1	NULL
antibodies	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
or	NULL
both	NULL
antibodies	NULL
(	NULL
Zane	NULL
6	NULL
)	NULL
,	NULL
indicated	NULL
that	NULL
these	NULL
two	NULL
bands	NULL
were	NULL
specific	NULL
complexes	NULL
formed	NULL
between	NULL
STAT1	NULL
and	NULL
Spl	NULL
.	NULL

When	NULL
excess	NULL
unlabeled	NULL
probes	NULL
containing	NULL
either	NULL
the	NULL
first	NULL
or	NULL
the	NULL
second	NULL
Spl	NULL
element	NULL
were	NULL
used	NULL
as	NULL
competitors	NULL
,	NULL
the	NULL
two	NULL
bands	NULL
were	NULL
also	NULL
competed	NULL
out	NULL
(	NULL
Zanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

When	NULL
unlabeled	NULL
probe	NULL
containing	NULL
only	NULL
the	NULL
first	NULL
two	NULL
mutant	NULL
or	NULL
all	NULL
four	NULL
mutant	NULL
Spl	NULL
elements	NULL
were	NULL
used	NULL
as	NULL
competitors	NULL
,	NULL
both	NULL
bands	NULL
moved	NULL
faster	NULL
(	NULL
Zanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
than	NULL
those	NULL
in	NULL
the	NULL
control	NULL
lane	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
.	NULL

These	NULL
two	NULL
bands	NULL
were	NULL
supershifted	NULL
by	NULL
using	NULL
the	NULL
anti-Spl	NULL
antibody	NULL
(	NULL
Zane	NULL
11	NULL
)	NULL
but	NULL
not	NULL
by	NULL
using	NULL
the	NULL
anti-STAT1	NULL
antibody	NULL
(	NULL
Zane	NULL
12	NULL
)	NULL
.	NULL

Additional	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

8D	NULL
)	NULL
showed	NULL
that	NULL
when	NULL
labeled	NULL
wild-type	NULL
DNA	NULL
fragments	NULL
were	NULL
used	NULL
as	NULL
probe	NULL
and	NULL
unlabeled	NULL
DNA	NULL
fragment	NULL
containing	NULL
all	NULL
four	NULL
wild-type	NULL
Spl	NULL
elements	NULL
and	NULL
the	NULL
mutant	NULL
GAS	NULL
(	NULL
GASm	NULL
)	NULL
as	NULL
competitors	NULL
,	NULL
one	NULL
band	NULL
was	NULL
found	NULL
to	NULL
move	NULL
faster	NULL
than	NULL
the	NULL
control	NULL
lane	NULL
(	NULL
comparing	NULL
lanes	NULL
4-6	NULL
with	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

This	NULL
band	NULL
was	NULL
supershifted	NULL
by	NULL
adding	NULL
anti-STAT1	NULL
antibody	NULL
,	NULL
but	NULL
not	NULL
by	NULL
adding	NULL
anti-Spl	NULL
antibody	NULL
(	NULL
comparing	NULL
lanes	NULL
4-6	NULL
)	NULL
.	NULL

When	NULL
labeled	NULL
probe	NULL
containing	NULL
mutant	NULL
GAS	NULL
was	NULL
used	NULL
,	NULL
two	NULL
bands	NULL
moved	NULL
faster	NULL
(	NULL
Zanes	NULL
8	NULL
)	NULL
;	NULL
they	NULL
were	NULL
supershifted	NULL
by	NULL
anti-Spl	NULL
antibody	NULL
but	NULL
not	NULL
by	NULL
anti-STAT1	NULL
antibody	NULL
(	NULL
comparing	NULL
lanes	NULL
10	NULL
and	NULL
11	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
demonstrate	NULL
that	NULL
the	NULL
first	NULL
two	NULL
Sp1	NULL
sites	NULL
and	NULL
the	NULL
GAS	NULL
site	NULL
are	NULL
functionally	NULL
important	NULL
,	NULL
and	NULL
that	NULL
the	NULL
second	NULL
Spl	NULL
site	NULL
overlaps	NULL
with	NULL
a	NULL
GAS	NULL
site	NULL
to	NULL
form	NULL
a	NULL
novel	NULL
overlapping	NULL
GAS/Spl	NULL
element	NULL
.	NULL

This	NULL
GAS/Spl	NULL
element	NULL
is	NULL
recognized	NULL
by	NULL
both	NULL
STAT1	NULL
and	NULL
Spl	NULL
present	NULL
in	NULL
the	NULL
nuclear	NULL
extracts	NULL
of	NULL
treated	NULL
THP-1	NULL
cells	NULL
.	NULL

ATRA	NULL
Induces	NULL
STAT1	NULL
Expression	NULL
,	NULL
While	NULL
IFN-y	NULL
Causes	NULL
the	NULL
STAT1	NULL
to	NULL
Dimerize	NULL
and	NULL
Bind	NULL
to	NULL
GAS	NULL
Element	NULL
in	NULL
the	NULL
ACAT-1	NULL
Promoter-STAT1	NULL
is	NULL
a	NULL
key	NULL
component	NULL
of	NULL
the	NULL
IFN-y-dependent	NULL
transcriptional	NULL
activation	NULL
complex	NULL
(	NULL
36	NULL
,	NULL
37	NULL
)	NULL
.	NULL

We	NULL
examined	NULL
the	NULL
transcript	NULL
level	NULL
of	NULL
STAT1	NULL
in	NULL
control	NULL
and	NULL
treated	NULL
THP-1	NULL
cells	NULL
by	NULL
RT-PCR	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

94	NULL
,	NULL
STATI	NULL
transcript	NULL
was	NULL
not	NULL
detectable	NULL
in	NULL
control	NULL
THP-1	NULL
cells	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
.	NULL

Treating	NULL
cells	NULL
with	NULL
ATRA	NULL
gave	NULL
rise	NULL
to	NULL
a	NULL
remarkable	NULL
increase	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
,	NULL
while	NULL
treating	NULL
cells	NULL
with	NULL
IFN-y	NULL
caused	NULL
only	NULL
a	NULL
modest	NULL
increase	NULL
in	NULL
the	NULL
STAT1	NULL
transcript	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Treating	NULL
cells	NULL
with	NULL
ATRA	NULL
with	NULL
or	NULL
without	NULL
IFN-y	NULL
caused	NULL
large	NULL
increases	NULL
in	NULL
similar	NULL
fashion	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
treating	NULL
THP-1	NULL
cells	NULL
with	NULL
ATRA	NULL
,	NULL
with	NULL
or	NULL
without	NULL
IFN-y	NULL
,	NULL
increased	NULL
significant	NULL
gene	NULL
expression	NULL
of	NULL
STAT1	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
STAT1	NULL
can	NULL
be	NULL
activated	NULL
as	NULL
a	NULL
homodimer	NULL
that	NULL
moves	NULL
into	NULL
the	NULL
nucleus	NULL
and	NULL
acts	NULL
as	NULL
a	NULL
mature	NULL
transcription	NULL
factor	NULL
by	NULL
binding	NULL
to	NULL
the	NULL
GAS	NULL
element	NULL
(	NULL
39	NULL
)	NULL
.	NULL

The	NULL
dimerization	NULL
of	NULL
STAT1	NULL
requires	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
in	NULL
a	NULL
manner	NULL
triggered	NULL
by	NULL
IFN-y	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Mutant	NULL
STAT1	NULL
(	NULL
STAT1-Y701Fm	NULL
,	NULL
replacing	NULL
tyrosine	NULL
701	NULL
with	NULL
phenyl-alanine	NULL
)	NULL
is	NULL
unable	NULL
to	NULL
undergo	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
dependent	NULL
dimerization	NULL
process	NULL
(	NULL
40	NULL
)	NULL
.	NULL

To	NULL
test	NULL
the	NULL
possibility	NULL
that	NULL
IFN-y	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
activating	NULL
STAT1	NULL
to	NULL
up-regulate	NULL
the	NULL
ACAT-1	NULL
gene	NULL
,	NULL
we	NULL
prepared	NULL
wild-type	NULL
STAT	NULL
cDNA	NULL
(	NULL
STATI1-Y701	NULL
)	NULL
and	NULL
the	NULL
mutant	NULL
STAT1	NULL
eDNA	NULL
(	NULL
STATI-Y701Fm	NULL
)	NULL
in	NULL
pRC/CMV	NULL
vector	NULL
.	NULL

We	NULL
then	NULL
transfected	NULL
these	NULL
constructs	NULL
in	NULL
20995	NULL
A	NULL
so	NULL
kp-	NULL
“	NULL
a	NULL
3	NULL
§	NULL
2	NULL
£2	NULL
.	NULL

$	NULL
11	NULL
0	NULL
IFN-7	NULL
=	NULL
+	NULL
=	NULL
+	NULL
ATRA	NULL
-	NULL
-	NULL
+	NULL
+	NULL
B	NULL
pee	NULL
T	NULL
3	NULL
al	NULL
c	NULL
3	NULL
al	NULL
.	NULL

3	NULL
§	NULL
a	NULL
%	NULL
+3	NULL
IL	NULL
I	NULL
md	NULL
Ac29	NULL
25RA	NULL
THP-1	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

IFN-y	NULL
and	NULL
ATRA	NULL
synergistically	NULL
increase	NULL
ACAT-1	NULL
protein	NULL
and	NULL
enzyme	NULL
activity	NULL
.	NULL

A	NULL
,	NULL
immunoblotting	NULL
of	NULL
ACAT-1	NULL
protein	NULL
from	NULL
extracts	NULL
of	NULL
THP-1	NULL
cells	NULL
were	NULL
treated	NULL
in	NULL
various	NULL
manners	NULL
as	NULL
indicated	NULL
.	NULL

Cells	NULL
were	NULL
seeded	NULL
at	NULL
2	NULL
X	NULL
10°/ml	NULL
in	NULL
60-mm	NULL
dishes	NULL
with	NULL
7.5	NULL
ml	NULL
of	NULL
medium	NULL
,	NULL
and	NULL
treated	NULL
for	NULL
40	NULL
h	NULL
with	NULL
or	NULL
without	NULL
IFN-y	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
,	NULL
or	NULL
with	NULL
ATRA	NULL
(	NULL
10~	NULL
``	NULL
M	NULL
)	NULL
or	NULL
IFN-y	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
plus	NULL
ATRA	NULL
(	NULL
10~°	NULL
M	NULL
)	NULL
as	NULL
indicated	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
immunoblotting	NULL
were	NULL
conducted	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

Samples	NULL
(	NULL
40	NULL
ug	NULL
of	NULL
protein/	NULL
lane	NULL
)	NULL
were	NULL
freshly	NULL
prepared	NULL
with	NULL
SDS	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
incubated	NULL
with	NULL
DM10	NULL
(	NULL
0.5	NULL
ug/ml	NULL
)	NULL
as	NULL
the	NULL
primary	NULL
antibody	NULL
.	NULL

The	NULL
immunoreactive	NULL
proteins	NULL
were	NULL
visualized	NULL
using	NULL
the	NULL
ECL	NULL
detection	NULL
system	NULL
and	NULL
autora-diography	NULL
.	NULL

The	NULL
intensities	NULL
of	NULL
bands	NULL
were	NULL
determined	NULL
by	NULL
using	NULL
the	NULL
UVP	NULL
Labwork	NULL
software	NULL
(	NULL
UVP	NULL
Inc.	NULL
)	NULL
.	NULL

The	NULL
data	NULL
are	NULL
expressed	NULL
as	NULL
relative	NULL
protein	NULL
using	NULL
the	NULL
value	NULL
in	NULL
untreated	NULL
THP-1	NULL
cells	NULL
as	NULL
1.0	NULL
.	NULL

The	NULL
ratios	NULL
of	NULL
the	NULL
protein	NULL
from	NULL
cells	NULL
treated	NULL
in	NULL
various	NULL
manners	NULL
as	NULL
indicated	NULL
were	NULL
shown	NULL
at	NULL
the	NULL
bottom	NULL
panel	NULL
.	NULL

B	NULL
,	NULL
ACAT	NULL
activity	NULL
assayed	NULL
in	NULL
vitro	NULL
.	NULL

AC29	NULL
,	NULL
25RA	NULL
,	NULL
and	NULL
THP-1	NULL
cells	NULL
were	NULL
cultured	NULL
at	NULL
2	NULL
X	NULL
10°/ml	NULL
in	NULL
60-mm	NULL
dishes	NULL
with	NULL
7.5	NULL
ml	NULL
of	NULL
medium	NULL
and	NULL
treated	NULL
for	NULL
40	NULL
h	NULL
with	NULL
or	NULL
without	NULL
IFN-y	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
,	NULL
or	NULL
with	NULL
ATRA	NULL
(	NULL
10~°	NULL
M	NULL
)	NULL
,	NULL
or	NULL
with	NULL
IFN-y	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
plus	NULL
ATRA	NULL
(	NULL
10~°	NULL
mM	NULL
)	NULL
as	NULL
indicated	NULL
.	NULL

ACAT	NULL
activities	NULL
were	NULL
assayed	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

The	NULL
data	NULL
are	NULL
expressed	NULL
as	NULL
relative	NULL
ACAT	NULL
activity	NULL
using	NULL
the	NULL
value	NULL
in	NULL
untreated	NULL
THP-1	NULL
cells	NULL
as	NULL
1.0	NULL
.	NULL

The	NULL
ACAT	NULL
specific	NULL
activity	NULL
in	NULL
untreated	NULL
cell	NULL
extracts	NULL
was	NULL
74	NULL
pmol/mg/min	NULL
.	NULL

dividually	NULL
into	NULL
the	NULL
IFN-y	NULL
and/or	NULL
ATRA-treated	NULL
THP-1	NULL
cells	NULL
,	NULL
and	NULL
measured	NULL
ACAT-1	NULL
P1	NULL
promoter	NULL
activity	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

9B	NULL
,	NULL
when	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
IFN-y	NULL
alone	NULL
,	NULL
a	NULL
significant	NULL
enhancement	NULL
of	NULL
the	NULL
P1	NULL
promoter	NULL
was	NULL
seen	NULL
when	NULL
these	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
wild-type	NULL
STAT1	NULL
cDNA	NULL
.	NULL

The	NULL
enhancement	NULL
was	NULL
not	NULL
seen	NULL
when	NULL
mutant	NULL
STAT1	NULL
cDNA	NULL
was	NULL
used	NULL
(	NULL
comparing	NULL
the	NULL
sizes	NULL
of	NULL
the	NULL
second	NULL
bar	NULL
in	NULL
the	NULL
STATI-Y701	NULL
panel	NULL
with	NULL
the	NULL
second	NULL
bar	NULL
in	NULL
the	NULL
STATI-Y701Fm	NULL
panel	NULL
)	NULL
.	NULL

These	NULL
results	NULL
imply	NULL
that	NULL
IFN-y	NULL
is	NULL
involved	NULL
in	NULL
stimulating	NULL
the	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
,	NULL
causing	NULL
the	NULL
dimeric	NULL
form	NULL
of	NULL
STAT1	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
GAS	NULL
element	NULL
.	NULL

To	NULL
further	NULL
test	NULL
this	NULL
interpretation	NULL
,	NULL
we	NULL
treated	NULL
THP-1	NULL
cells	NULL
with	NULL
IFN-y	NULL
alone	NULL
,	NULL
and	NULL
transfected	NULL
with	NULL
or	NULL
without	NULL
the	NULL
wild-type	NULL
or	NULL
the	NULL
mutant	NULL
STATZI	NULL
cDNAs	NULL
,	NULL
then	NULL
prepared	NULL
the	NULL
nuclear	NULL
extracts	NULL
of	NULL
these	NULL
cells	NULL
and	NULL
performed	NULL
EMSAs	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

9C	NULL
,	NULL
the	NULL
two	NULL
GAS-specific	NULL
bands	NULL
were	NULL
detectable	NULL
in	NULL
the	NULL
nuclear	NULL
extracts	NULL
of	NULL
cells	NULL
transfected	NULL
with	NULL
wild-type	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Activation	NULL
of	NULL
ACAT-1	NULL
by	NULL
IFN-y	NULL
in	NULL
Foam	NULL
Cell	NULL
Formation	NULL
A	NULL
B	NULL
Gas	NULL
y	NULL
activated	NULL
P	NULL
Relative	NULL
luciferase	NULL
activity	NULL
(	NULL
fold	NULL
)	NULL
Spt	NULL
Sp	NULL
!	NULL

Spl	NULL
Spi	NULL
e	NULL
(	NULL
GAS	NULL
)	NULL
is	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
m	NULL
-a	NULL
Spi	NULL
Spl	NULL
Spl	NULL
Spl	NULL
+04	NULL
10+	NULL
i	NULL
seray	NULL
.	NULL

wild	NULL
GAS	NULL
mutant	NULL
Anti-STAT1	NULL
antibody	NULL
-	NULL
-	NULL
-	NULL
-	NULL
+	NULL
+	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
+	NULL
_	NULL
A	NULL
C	NULL
ly	NULL
A	NULL
o	NULL
Anti-Sp1	NULL
antibody	NULL
=	NULL
-	NULL
=	NULL
+	NULL
-	NULL
+	NULL
-	NULL
-	NULL
-	NULL
-	NULL
+	NULL
-	NULL
Anti-STAT1	NULL
antibody	NULL
~	NULL
~	NULL
-	NULL
-	NULL
-	NULL
\	NULL
-	NULL
-	NULL
m	NULL
+	NULL
2	NULL
100	NULL
ng	NULL
Sp1-1234m	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
Anti-Sp1	NULL
antibody	NULL
-	NULL
-	NULL
-	NULL
-	NULL
+	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
+	NULL
100	NULL
ng	NULL
Sp1-12m	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
+	NULL
-	NULL
-	NULL
-	NULL
100	NULL
ng	NULL
GASm	NULL
-	NULL
-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
m	NULL
-	NULL
-	NULL
-	NULL
M	NULL
100	NULL
ng	NULL
Sp1-2m	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
+	NULL
-	NULL
-	NULL
-	NULL
-	NULL
100	NULL
ng	NULL
cold	NULL
probe	NULL
-	NULL
-	NULL
+	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
+	NULL
-	NULL
100	NULL
ng	NULL
Sp1-Im	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-o	NULL
+	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
10	NULL
ug	NULL
nuclear	NULL
extract	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
100	NULL
ng	NULL
cold	NULL
probe	NULL
800-0	NULL
&	NULL
o-	NULL
~	NULL
``	NULL
He	NULL
£0	NULL
-	NULL
~	NULL
~	NULL
-	NULL
3	NULL
ug	NULL
poly	NULL
(	NULL
dl-dC	NULL
)	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
10	NULL
pg	NULL
nuclear	NULL
extract	NULL
S	NULL
o	NULL
o	NULL
o	NULL
e	NULL
a	NULL
e	NULL
e.	NULL
I	NULL
ng	NULL
[	NULL
``	NULL
P	NULL
}	NULL
-labeled	NULL
probe	NULL
_+	NULL
_	NULL
#	NULL
_	NULL
#	NULL
_	NULL
+	NULL
_	NULL
%	NULL
_	NULL
%	NULL
_	NULL
#	NULL
4	NULL
+	NULL
%	NULL
+	NULL
3	NULL
us	NULL
poly	NULL
(	NULL
dl-dC	NULL
)	NULL
+o	NULL
ko	NULL
40	NULL
$	NULL
0	NULL
#	NULL
0	NULL
#	NULL
0	NULL
o	NULL
$	NULL
o	NULL
#	NULL
0	NULL
#	NULL
0	NULL
40	NULL
#	NULL
0	NULL
o+	NULL
#	NULL
1	NULL
ng	NULL
[	NULL
``	NULL
P	NULL
]	NULL
-labeled	NULL
probe	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
F	NULL
#	NULL
|	NULL
an	NULL
f	NULL
a	NULL
Gas	NULL
ham	NULL
Spi	NULL
Spl	NULL
Spi	NULL
Spi	NULL
bed	NULL
rt	NULL
E-	NULL
+4	NULL
pe	NULL
Cho	NULL
®	NULL
--	NULL
-	NULL
amt	NULL
**	NULL
4.63	NULL
tes	NULL
wild	NULL
prot	NULL
pect	NULL
on	NULL
n.	NULL
lid	NULL
£	NULL
GAS	NULL
Spt	NULL
Sp1	NULL
Spt	NULL
Spl	NULL
yeu	NULL
4	NULL
++	NULL
bad	NULL
£5	NULL
i	NULL
Spl	NULL
Sp	NULL
Spl	NULL
Spl	NULL
Wild	NULL
GAS	NULL
mutant	NULL
I	NULL
ro	NULL
m	NULL
5	NULL
se	NULL
©	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
functional	NULL
GAS	NULL
element	NULL
in	NULL
ACAT-I	NULL
P1	NULL
promoter	NULL
.	NULL

A	NULL
,	NULL
individual	NULL
Lue	NULL
constructs	NULL
containing	NULL
the	NULL
159-bp	NULL
core	NULL
region	NULL
(	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
panel	NULL
;	NULL
with	NULL
wild-type	NULL
at	NULL
the	NULL
top	NULL
,	NULL
two	NULL
different	NULL
deletions	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
middle	NULL
or	NULL
the	NULL
bottom	NULL
)	NULL
were	NULL
transfected	NULL
into	NULL
THP-1	NULL
cells	NULL
.	NULL

7	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
IFN-y	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
,	NULL
or	NULL
with	NULL
ATRA	NULL
(	NULL
10~®	NULL
M	NULL
)	NULL
,	NULL
or	NULL
with	NULL
IFN-y	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
plus	NULL
ATRA	NULL
(	NULL
10~	NULL
``	NULL
M	NULL
)	NULL
as	NULL
indicated	NULL
for	NULL
40	NULL
h.	NULL
Results	NULL
of	NULL
luciferase	NULL
activities	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
right	NULL
panel	NULL
.	NULL

B	NULL
,	NULL
individual	NULL
Luc	NULL
constructs	NULL
with	NULL
or	NULL
without	NULL
various	NULL
mutations	NULL
in	NULL
Spl	NULL
or	NULL
in	NULL
GAS	NULL
(	NULL
as	NULL
indicated	NULL
on	NULL
the	NULL
/eft	NULL
panel	NULL
)	NULL
were	NULL
transfected	NULL
into	NULL
THP-1	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
and	NULL
assayed	NULL
in	NULL
the	NULL
same	NULL
way	NULL
as	NULL
described	NULL
in	NULL
A	NULL
.	NULL

C	NULL
and	NULL
D	NULL
,	NULL
EMSAs	NULL
using	NULL
nuclear	NULL
extracts	NULL
of	NULL
THP-1	NULL
cells	NULL
treated	NULL
for	NULL
40	NULL
h	NULL
with	NULL
IFN-y	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
plus	NULL
ATRA	NULL
(	NULL
10~°	NULL
M	NULL
)	NULL
.	NULL

The	NULL
wild-type	NULL
and	NULL
mutant	NULL
GAS	NULL
DNA	NULL
fragments	NULL
as	NULL
indicated	NULL
were	NULL
labeled	NULL
;	NULL
1	NULL
X	NULL
10	NULL
``	NULL
dpm	NULL
of	NULL
labeled	NULL
probe	NULL
was	NULL
used	NULL
in	NULL
each	NULL
binding	NULL
reaction	NULL
.	NULL

C	NULL
,	NULL
lane	NULL
1	NULL
,	NULL
*°P-labeled	NULL
wild-type	NULL
fragment	NULL
as	NULL
the	NULL
probe	NULL
alone	NULL
serving	NULL
as	NULL
negative	NULL
control	NULL
.	NULL

Lane	NULL
2	NULL
,	NULL
binding	NULL
reaction	NULL
between	NULL
labeled	NULL
probe	NULL
and	NULL
the	NULL
nuclear	NULL
extracts	NULL
.	NULL

Lane	NULL
3	NULL
,	NULL
competition	NULL
by	NULL
adding	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
cold	NULL
wild-type	NULL
probe	NULL
;	NULL
Zanes	NULL
4-6	NULL
,	NULL
supershift	NULL
reactions	NULL
by	NULL
adding	NULL
1	NULL
pl	NULL
of	NULL
anti-Spl	NULL
antibody	NULL
,	NULL
1	NULL
ul	NULL
of	NULL
anti-STAT1	NULL
antibody	NULL
,	NULL
or	NULL
1	NULL
pl	NULL
of	NULL
anti-Spl	NULL
antibody	NULL
and	NULL
1	NULL
ul	NULL
of	NULL
anti-STAT1	NULL
antibody	NULL
as	NULL
indicated	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
;	NULL
Zanes	NULL
7-10	NULL
,	NULL
competition	NULL
by	NULL
adding	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
probe	NULL
containing	NULL
mutation	NULL
within	NULL
the	NULL
first	NULL
,	NULL
or	NULL
second	NULL
,	NULL
or	NULL
the	NULL
first	NULL
two	NULL
,	NULL
or	NULL
all	NULL
four	NULL
Spl	NULL
elements	NULL
as	NULL
indicated	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
;	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
,	NULL
supershift	NULL
reactions	NULL
by	NULL
adding	NULL
1	NULL
pl	NULL
of	NULL
anti-Sp1l	NULL
antibody	NULL
or	NULL
1	NULL
pl	NULL
of	NULL
anti-STAT1	NULL
antibody	NULL
as	NULL
indicated	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
described	NULL
for	NULL
lane	NULL
10	NULL
.	NULL

D	NULL
,	NULL
lanes	NULL
1-3	NULL
,	NULL
the	NULL
same	NULL
conditions	NULL
as	NULL
described	NULL
for	NULL
Fig	NULL
.	NULL

7C	NULL
,	NULL
lane	NULL
1-3	NULL
,	NULL
were	NULL
employed	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
competition	NULL
by	NULL
adding	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
probe	NULL
containing	NULL
the	NULL
mutant	NULL
GAS	NULL
element	NULL
;	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
,	NULL
supershift	NULL
reactions	NULL
by	NULL
adding	NULL
1	NULL
pl	NULL
of	NULL
anti-Spl	NULL
antibody	NULL
or	NULL
anti-STAT1	NULL
antibody	NULL
as	NULL
indicated	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
described	NULL
for	NULL
lane	NULL
4	NULL
;	NULL
lanes	NULL
7-9	NULL
,	NULL
the	NULL
same	NULL
conditions	NULL
as	NULL
described	NULL
for	NULL
lames	NULL
1-3	NULL
were	NULL
employed	NULL
,	NULL
except	NULL
the	NULL
mutant	NULL
GAS	NULL
DNA	NULL
fragment	NULL
was	NULL
used	NULL
as	NULL
the	NULL
labeled	NULL
probe	NULL
;	NULL
lanes	NULL
10	NULL
and	NULL
11	NULL
,	NULL
supershift	NULL
reactions	NULL
by	NULL
adding	NULL
1	NULL
ul	NULL
of	NULL
anti-STAT1	NULL
antibody	NULL
or	NULL
anti-Spl	NULL
antibody	NULL
as	NULL
indicated	NULL
to	NULL
the	NULL
binding	NULL
reactions	NULL
described	NULL
in	NULL
Zane	NULL
8	NULL
.	NULL

STAT1	NULL
cDNA	NULL
(	NULL
comparing	NULL
lane	NULL
6	NULL
with	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

These	NULL
two	NULL
bands	NULL
were	NULL
not	NULL
detectable	NULL
in	NULL
extracts	NULL
of	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
mutant	NULL
STATI	NULL
cDNA	NULL
(	NULL
comparing	NULL
lane	NULL
10	NULL
with	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Results	NULL
of	NULL
the	NULL
gel	NULL
supershift	NULL
assays	NULL
using	NULL
anti-STAT1	NULL
and	NULL
anti-Spl	NULL
antibodies	NULL
confirmed	NULL
that	NULL
these	NULL
two	NULL
bands	NULL
were	NULL
complexes	NULL
resulting	NULL
from	NULL
specific	NULL
interactions	NULL
of	NULL
STAT1	NULL
and	NULL
Spl	NULL
with	NULL
the	NULL
ACAT-1	NULL
P1	NULL
promoter	NULL
(	NULL
Zanes	NULL
8	NULL
and	NULL
9	NULL
)	NULL
.	NULL

Additional	NULL
EMSAs	NULL
,	NULL
using	NULL
the	NULL
nuclear	NULL
extracts	NULL
from	NULL
control	NULL
(	NULL
untransfected	NULL
)	NULL
THP-1	NULL
cells	NULL
or	NULL
from	NULL
mutant	NULL
cDNA-transfected	NULL
cells	NULL
showed	NULL
that	NULL
the	NULL
two	NULL
bands	NULL
described	NULL
above	NULL
migrated	NULL
faster	NULL
.	NULL

These	NULL
bands	NULL
were	NULL
not	NULL
supershifted	NULL
with	NULL
anti-STAT1	NULL
antibodies	NULL
,	NULL
but	NULL
were	NULL
supershifted	NULL
with	NULL
anti-Spl	NULL
antibodies	NULL
(	NULL
comparing	NULL
lane	NULL
4	NULL
and	NULL
5	NULL
with	NULL
12	NULL
and	NULL
13	NULL
)	NULL
.	NULL

These	NULL
results	NULL
showed	NULL
that	NULL
the	NULL
GAS	NULL
site	NULL
,	NULL
not	NULL
the	NULL
Spl	NULL
sites	NULL
,	NULL
formed	NULL
specific	NULL
complexes	NULL
with	NULL
the	NULL
wild-type	NULL
STAT1	NULL
after	NULL
activation	NULL
by	NULL
IFN-y	NULL
through	NULL
the	NULL
tyrosine-phosphorylation	NULL
dependent	NULL
mechanism	NULL
.	NULL

DISCUSSION	NULL
ACAT-1	NULL
mRNAs	NULL
and	NULL
protein	NULL
contents	NULL
are	NULL
significantly	NULL
increased	NULL
during	NULL
the	NULL
human	NULL
monocyte-macrophage	NULL
differentiation	NULL
process	NULL
in	NULL
vitro	NULL
(	NULL
21	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Its	NULL
protein	NULL
content	NULL
is	NULL
amply	NULL
present	NULL
in	NULL
macrophage-derived	NULL
foam	NULL
cells	NULL
localized	NULL
in	NULL
the	NULL
human	NULL
atherosclerotic	NULL
lesion	NULL
,	NULL
implying	NULL
that	NULL
up-regulation	NULL
of	NULL
the	NULL
ACAT-1	NULL
gene	NULL
plays	NULL
important	NULL
roles	NULL
in	NULL
macrophage	NULL
foam	NULL
cell	NULL
formation	NULL
in	NULL
atherosclerosis	NULL
(	NULL
42	NULL
)	NULL
.	NULL

In	NULL
mouse	NULL
macrophages	NULL
,	NULL
ACAT-1	NULL
message	NULL
was	NULL
found	NULL
to	NULL
be	NULL
up-regulated	NULL
by	NULL
cells	NULL
with	NULL
IFN-y	NULL
(	NULL
12	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
basis	NULL
of	NULL
these	NULL
findings	NULL
has	NULL
not	NULL
been	NULL
pursued	NULL
at	NULL
the	NULL
gene	NULL
transcription	NULL
level	NULL
.	NULL

In	NULL
our	NULL
current	NULL
work	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
IFN-y	NULL
increased	NULL
ACAT-1	NULL
mRNAs	NULL
and	NULL
protein	NULL
contents	NULL
during	NULL
the	NULL
human	NULL
blood	NULL
monocyte-macrophage	NULL
differentiation	NULL
process	NULL
.	NULL

We	NULL
then	NULL
found	NULL
that	NULL
treating	NULL
the	NULL
human	NULL
monocyte-like	NULL
THP-1	NULL
cells	NULL
with	NULL
ATRA	NULL
and	NULL
IFN-y	NULL
caused	NULL
up-regulation	NULL
of	NULL
ACAT-1	NULL
gene	NULL
expression	NULL
in	NULL
cell-type	NULL
specific	NULL
man-ner	NULL
.	NULL

To	NULL
elucidate	NULL
the	NULL
molecular	NULL
basis	NULL
of	NULL
this	NULL
finding	NULL
,	NULL
we	NULL
identified	NULL
a	NULL
159-bp	NULL
core	NULL
region	NULL
with	NULL
Spl	NULL
elements	NULL
that	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
P1	NULL
promoter	NULL
activity	NULL
.	NULL

This	NULL
region	NULL
also	NULL
contains	NULL
an	NULL
IFN-y	NULL
activated	NULL
sequence	NULL
(	NULL
GAS	NULL
)	NULL
that	NULL
overlaps	NULL
exactly	NULL
with	NULL
the	NULL
second	NULL
Spl	NULL
element	NULL
(	NULL
TGGGCGGAA	NULL
,	NULL
with	NULL
the	NULL
Spl	NULL
site	NULL
underlined	NULL
)	NULL
.	NULL

To	NULL
our	NULL
knowledge	NULL
,	NULL
this	NULL
is	NULL
the	NULL
first	NULL
example	NULL
in	NULL
literature	NULL
describing	NULL
an	NULL
overlapping	NULL
SpLGAS	NULL
site	NULL
.	NULL

Using	NULL
luciferase	NULL
constructs	NULL
in	NULL
transient	NULL
trasfection	NULL
studies	NULL
,	NULL
we	NULL
demon	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Activation	NULL
of	NULL
ACAT-1	NULL
by	NULL
IFN-y	NULL
in	NULL
Foam	NULL
Cell	NULL
Formation	NULL
A	NULL
20	NULL
&	NULL
is	NULL
§	NULL
10	NULL
=	NULL
os	NULL
0	NULL
IFNy	NULL
=	NULL
+	NULL
A	NULL
£	NULL
ATRA	NULL
-	NULL
~	NULL
+	NULL
+	NULL
B	NULL
IFNy	NULL
-	NULL
4+	NULL
-	NULL
+	NULL
-o	NULL
¥	NULL
-	NULL
+	NULL
-	NULL
£	NULL
-	NULL
%	NULL
ATRA	NULL
|	NULL
-	NULL
-	NULL
+	NULL
+	NULL
-o-	NULL
40+	NULL
-o-	NULL
+o+	NULL
Control	NULL
STATI-¥701	NULL
-	NULL
STATI-¥701Fm	NULL
C	NULL
Control	NULL
STATI-¥701	NULL
STAT1-¥701Fm	NULL
A	NULL
a	NULL
``	NULL
Anti-STATI	NULL
antibedy	NULL
|	NULL
Lo	NULL
-	NULL
-	NULL
-	NULL
&	NULL
C-	NULL
-	NULL
-	NULL
@	NULL
CI	NULL
2	NULL
2	NULL
Anti-Spl	NULL
antibody	NULL
<	NULL
0	NULL
>	NULL
0	NULL
>	NULL
0	NULL
&	NULL
00	NULL
>	NULL
o	NULL
>	NULL
o	NULL
>	NULL
#	NULL
0c=	NULL
-o	NULL
4	NULL
00	NULL
>	NULL
100	NULL
ng	NULL
cold	NULL
probe	NULL
#	NULL
0	NULL
>	NULL
08	NULL
>	NULL
o	NULL
>	NULL
&	NULL
00	NULL
>	NULL
o	NULL
>	NULL
o	NULL
>	NULL
#	NULL
o	NULL
>	NULL
10	NULL
pg	NULL
nuclear	NULL
extract	NULL
h	NULL
+o	NULL
+	NULL
o	NULL
#	NULL
+	NULL
+0	NULL
+	NULL
+oo+	NULL
+	NULL
+o	NULL
3	NULL
ug	NULL
poly	NULL
(	NULL
dl-dC	NULL
)	NULL
+o	NULL
boob	NULL
b	NULL
¢	NULL
¢	NULL
bok	NULL
b	NULL
¢	NULL
&	NULL
+	NULL
+	NULL
I	NULL
ng	NULL
[	NULL
PP	NULL
}	NULL
-labeled	NULL
probe	NULL
_+	NULL
_	NULL
+	NULL
+	NULL
%	NULL
+	NULL
%	NULL
%	NULL
%	NULL
o	NULL
#	NULL
O+	NULL
O+	NULL
+0	NULL
+	NULL
GAS	NULL
Spi	NULL
Sp	NULL
Spi	NULL
Sp	NULL
Wild	NULL
Fic	NULL
.	NULL

9	NULL
.	NULL

STAT1	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
synergistic	NULL
effect	NULL
of	NULL
IFN-y	NULL
and	NULL
ATRA	NULL
.	NULL

Total	NULL
RNAs	NULL
were	NULL
prepared	NULL
from	NULL
THP-1	NULL
cells	NULL
treated	NULL
for	NULL
40	NULL
h	NULL
with	NULL
or	NULL
without	NULL
IFN-y	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
,	NULL
or	NULL
ATRA	NULL
(	NULL
10~°	NULL
M	NULL
)	NULL
,	NULL
or	NULL
IFN-y	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
plus	NULL
ATRA	NULL
(	NULL
10~°	NULL
M	NULL
)	NULL
as	NULL
indicated	NULL
.	NULL

A	NULL
,	NULL
quantitation	NULL
by	NULL
RT-PCR	NULL
(	NULL
30	NULL
cycles	NULL
)	NULL
.	NULL

Primers	NULL
were	NULL
used	NULL
for	NULL
STAT1	NULL
and	NULL
the	NULL
GAPDH	NULL
cDNAs	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

Control	NULL
experiments	NULL
indicated	NULL
that	NULL
between	NULL
cycles	NULL
25	NULL
and	NULL
35	NULL
,	NULL
the	NULL
IFN-y	NULL
receptor	NULL
transcripts	NULL
and	NULL
the	NULL
STAT1	NULL
transcript	NULL
could	NULL
be	NULL
estimated	NULL
semiquantitatively	NULL
by	NULL
RT-PCR	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

B	NULL
,	NULL
THP-1	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
the	NULL
Lue	NULL
construct	NULL
containing	NULL
the	NULL
wild-type	NULL
ACAT-1	NULL
Pl	NULL
promoter	NULL
core	NULL
region	NULL
,	NULL
and	NULL
the	NULL
wild-type	NULL
STAT1	NULL
(	NULL
indicated	NULL
as	NULL
STAT1-Y701	NULL
)	NULL
,	NULL
or	NULL
the	NULL
mutant	NULL
STAT1	NULL
(	NULL
indicated	NULL
as	NULL
STAT1-Y701F	NULL
'm	NULL
)	NULL
,	NULL
or	NULL
the	NULL
empty	NULL
vector	NULL
(	NULL
indicated	NULL
as	NULL
control	NULL
)	NULL
.	NULL

7	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
treated	NULL
in	NULL
various	NULL
manners	NULL
as	NULL
indicated	NULL
for	NULL
40	NULL
h.	NULL
The	NULL
luciferase	NULL
activities	NULL
of	NULL
treated	NULL
cell	NULL
extracts	NULL
were	NULL
then	NULL
determined	NULL
in	NULL
the	NULL
same	NULL
way	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1A	NULL
.	NULL

C	NULL
,	NULL
EMSAs	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
transfected	NULL
THP-1	NULL
cells	NULL
treated	NULL
for	NULL
40	NULL
h	NULL
with	NULL
IFN-y	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
.	NULL

The	NULL
wild-type	NULL
159-bp	NULL
core	NULL
region	NULL
DNA	NULL
was	NULL
labeled	NULL
as	NULL
probe	NULL
;	NULL
1	NULL
X	NULL
10	NULL
``	NULL
dpm	NULL
of	NULL
labeled	NULL
probe	NULL
was	NULL
used	NULL
for	NULL
each	NULL
binding	NULL
reaction	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
*°P-labeled	NULL
probe	NULL
alone	NULL
.	NULL

Lane	NULL
2	NULL
,	NULL
binding	NULL
reaction	NULL
between	NULL
labeled	NULL
probe	NULL
and	NULL
the	NULL
nuclear	NULL
extracts	NULL
.	NULL

Lane	NULL
3	NULL
,	NULL
competition	NULL
by	NULL
adding	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
cold	NULL
probe	NULL
.	NULL

Lane	NULL
4	NULL
,	NULL
supershift	NULL
reaction	NULL
by	NULL
adding	NULL
1	NULL
ul	NULL
of	NULL
anti-Spl	NULL
antibody	NULL
.	NULL

Lane	NULL
5	NULL
,	NULL
supershift	NULL
reaction	NULL
by	NULL
adding	NULL
1	NULL
ul	NULL
of	NULL
anti-STAT1	NULL
antibody	NULL
.	NULL

For	NULL
lanes	NULL
2-5	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
.	NULL

Lanes	NULL
6-9	NULL
and	NULL
10-13	NULL
are	NULL
results	NULL
using	NULL
the	NULL
same	NULL
series	NULL
of	NULL
reaction	NULL
conditions	NULL
as	NULL
described	NULL
in	NULL
lanes	NULL
2-5	NULL
,	NULL
but	NULL
using	NULL
the	NULL
nucleic	NULL
extracts	NULL
from	NULL
THP-1	NULL
cells	NULL
transfected	NULL
with	NULL
wild-type	NULL
STAT1	NULL
cDNA	NULL
or	NULL
with	NULL
mutant	NULL
STAT1	NULL
eDNA	NULL
,	NULL
respectively	NULL
.	NULL

strated	NULL
that	NULL
the	NULL
combination	NULL
of	NULL
IFN-y	NULL
and	NULL
ATRA	NULL
is	NULL
needed	NULL
to	NULL
enhance	NULL
ACAT-1	NULL
P1	NULL
promoter	NULL
activity	NULL
.	NULL

Additional	NULL
experiments	NULL
using	NULL
RT-PCR	NULL
and	NULL
EMSA	NULL
showed	NULL
that	NULL
ATRA	NULL
caused	NULL
large	NULL
induction	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
STAT1	NULL
,	NULL
while	NULL
IFN-y	NULL
triggered	NULL
the	NULL
phosphorylation	NULL
dependent	NULL
activation	NULL
of	NULL
STAT1	NULL
.	NULL

The	NULL
20997	NULL
activated	NULL
STAT1	NULL
then	NULL
acts	NULL
by	NULL
binding	NULL
to	NULL
the	NULL
overlapping	NULL
GAS	NULL
Spl	NULL
site	NULL
in	NULL
the	NULL
ACAT-1	NULL
P1	NULL
promoter	NULL
.	NULL

Our	NULL
work	NULL
dissects	NULL
the	NULL
non-sterol-mediated	NULL
ACAT	NULL
regulation	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
,	NULL
and	NULL
provides	NULL
a	NULL
molecular	NULL
mechanism	NULL
to	NULL
account	NULL
for	NULL
part	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
IFN-y	NULL
in	NULL
causing	NULL
macrophage	NULL
foam	NULL
cell	NULL
formation	NULL
in	NULL
vitro	NULL
.	NULL

In	NULL
atherosclerosis	NULL
,	NULL
the	NULL
infiltration	NULL
of	NULL
T-cells	NULL
and	NULL
monocyte-derived	NULL
macrophages	NULL
into	NULL
the	NULL
intimal	NULL
layer	NULL
of	NULL
the	NULL
artery	NULL
is	NULL
believed	NULL
to	NULL
lead	NULL
to	NULL
foam	NULL
cell	NULL
formation	NULL
.	NULL

Activated	NULL
T	NULL
cells	NULL
found	NULL
in	NULL
human	NULL
atheroma	NULL
secrete	NULL
high	NULL
levels	NULL
of	NULL
IFN-y	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

IFN-y	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
exert	NULL
certain	NULL
proatherosclerogenic	NULL
actions	NULL
in	NULL
vitro	NULL
.	NULL

It	NULL
induces	NULL
VCAM-1	NULL
on	NULL
endothelial	NULL
cells	NULL
(	NULL
45	NULL
)	NULL
,	NULL
decreases	NULL
apoE	NULL
secretion	NULL
,	NULL
and	NULL
increases	NULL
uptake	NULL
of	NULL
hypertriblyderidemic	NULL
very	NULL
low	NULL
density	NULL
lipoprotein	NULL
on	NULL
macrophages	NULL
(	NULL
46	NULL
)	NULL
,	NULL
induces	NULL
my-osin	NULL
heavy	NULL
chain-II	NULL
on	NULL
macrophages	NULL
and	NULL
smooth	NULL
muscle	NULL
cells	NULL
(	NULL
47	NULL
)	NULL
,	NULL
and	NULL
induces	NULL
scavenger	NULL
receptors	NULL
on	NULL
smooth	NULL
muscle	NULL
cells	NULL
during	NULL
atherogenesis	NULL
(	NULL
48	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
IFN-y	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
exert	NULL
protective	NULL
action	NULL
against	NULL
atherosclerosis	NULL
in	NULL
certain	NULL
in	NULL
vitro	NULL
systems	NULL
examined	NULL
(	NULL
49	NULL
,	NULL
50	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
apoE	NULL
knockout	NULL
mice	NULL
crossed	NULL
with	NULL
the	NULL
IFN-y	NULL
receptor	NULL
knockout	NULL
mice	NULL
display	NULL
reductions	NULL
in	NULL
lesion	NULL
size	NULL
,	NULL
lipid	NULL
accumulation	NULL
,	NULL
and	NULL
cellularity	NULL
(	NULL
51	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
in	NULL
mice	NULL
,	NULL
post-transplant	NULL
graft	NULL
arteriosclerosis	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
IFN-y	NULL
;	NULL
the	NULL
serological	NULL
neutralization	NULL
or	NULL
the	NULL
genetic	NULL
absence	NULL
of	NULL
IFN-y	NULL
markedly	NULL
reduces	NULL
the	NULL
extent	NULL
of	NULL
intimal	NULL
expansion	NULL
(	NULL
52	NULL
)	NULL
.	NULL

These	NULL
results	NULL
support	NULL
the	NULL
notion	NULL
that	NULL
IFN-y	NULL
is	NULL
pro-atherogenic	NULL
in	NULL
vivo	NULL
.	NULL

If	NULL
this	NULL
concept	NULL
holds	NULL
true	NULL
,	NULL
then	NULL
our	NULL
finding	NULL
described	NULL
here	NULL
may	NULL
explain	NULL
some	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
IFN-y	NULL
on	NULL
foam	NULL
cell	NULL
formation	NULL
in	NULL
vivo	NULL
.	NULL

IFN-y	NULL
exhibits	NULL
antigrowth	NULL
or	NULL
antiproliferation	NULL
effects	NULL
in	NULL
various	NULL
target	NULL
cells	NULL
.	NULL

Its	NULL
effects	NULL
often	NULL
occur	NULL
synergistically	NULL
with	NULL
retinoids	NULL
(	NULL
53	NULL
)	NULL
.	NULL

To	NULL
cite	NULL
a	NULL
few	NULL
examples	NULL
,	NULL
in	NULL
various	NULL
myelogenous	NULL
leukemic	NULL
cell	NULL
lines	NULL
,	NULL
Gianni	NULL
et	NULL
al	NULL
.	NULL

(	NULL
54	NULL
)	NULL
showed	NULL
that	NULL
ATRA	NULL
can	NULL
bypass	NULL
IFEN/IFN	NULL
receptors	NULL
and	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
IFN-regulated	NULL
genes	NULL
including	NULL
STATI	NULL
;	NULL
Matikainen	NULL
et	NULL
al	NULL
.	NULL

(	NULL
55	NULL
,	NULL
56	NULL
)	NULL
showed	NULL
that	NULL
ATRA	NULL
causes	NULL
up-regulation	NULL
of	NULL
several	NULL
IFN-specific	NULL
transcription	NULL
factors	NULL
and	NULL
signal	NULL
inducers	NULL
including	NULL
STAT	NULL
,	NULL
and	NULL
enhances	NULL
their	NULL
responsiveness	NULL
toward	NULL
IFNs	NULL
.	NULL

The	NULL
molecular	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
for	NULL
the	NULL
synergism	NULL
observed	NULL
between	NULL
ATRA	NULL
and	NULL
IFNs	NULL
in	NULL
these	NULL
studies	NULL
remain	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

Our	NULL
work	NULL
described	NULL
here	NULL
may	NULL
serve	NULL
to	NULL
explain	NULL
some	NULL
of	NULL
the	NULL
synergistic	NULL
ac	NULL
tions	NULL
of	NULL
ATRA	NULL
and	NULL
IFNs	NULL
described	NULL
in	NULL
these	NULL
studies	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Dr.	NULL
Darnell	NULL
for	NULL
wild-type	NULL
STATI	NULL
cDNA	NULL
,	NULL
and	NULL
Dr.	NULL
Xinyuan	NULL
Liu	NULL
for	NULL
the	NULL
gifts	NULL
of	NULL
recombinant	NULL
IFN-y	NULL
.	NULL

We	NULL
also	NULL
acknowledge	NULL
Deng-Hong	NULL
Zhang	NULL
for	NULL
participating	NULL
in	NULL
certain	NULL
stages	NULL
of	NULL
this	NULL
work	NULL
,	NULL
and	NULL
thank	NULL
Bao-Liang	NULL
Song	NULL
,	NULL
Nian-Yi	NULL
Zhang	NULL
,	NULL
and	NULL
Wei	NULL
Qi	NULL
for	NULL
helpful	NULL
discussions	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Chang	NULL
,	NULL
T.	NULL
Y.	NULL
,	NULL
Chang	NULL
,	NULL
C.	NULL
C.	NULL
Y.	NULL
,	NULL
and	NULL
Cheng	NULL
,	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

66	NULL
,	NULL
613-638	NULL
2	NULL
.	NULL

Chang	NULL
,	NULL
C.	NULL
C.	NULL
Y.	NULL
,	NULL
Hub	NULL
,	NULL
H.	NULL
Y.	NULL
,	NULL
Cadigan	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
and	NULL
Chang	NULL
,	NULL
T.	NULL
Y	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
20747-20755	NULL
3	NULL
.	NULL

Anderson	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Joyce	NULL
,	NULL
C.	NULL
,	NULL
Davis	NULL
,	NULL
M.	NULL
,	NULL
Reagan	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Clark	NULL
,	NULL
M.	NULL
,	NULL
Shelness	NULL
,	NULL
G.	NULL
S.	NULL
,	NULL
and	NULL
Rudel	NULL
,	NULL
L.	NULL
L.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

278	NULL
,	NULL
26747-26754	NULL
4	NULL
.	NULL

Cases	NULL
,	NULL
S.	NULL
,	NULL
Novak	NULL
,	NULL
S.	NULL
,	NULL
Zheng	NULL
,	NULL
Y.	NULL
W.	NULL
,	NULL
Myers	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Lear	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Sande	NULL
,	NULL
E.	NULL
,	NULL
Welch	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
Lusis	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Spencer	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Krause	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
Erickson	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
and	NULL
Farese	NULL
,	NULL
R.	NULL
V.	NULL
,	NULL
Jr.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

278	NULL
,	NULL
26755-26764	NULL
5	NULL
.	NULL

Oelkers	NULL
,	NULL
P.	NULL
,	NULL
Behari	NULL
,	NULL
A.	NULL
,	NULL
Cromley	NULL
,	NULL
D.	NULL
,	NULL
Billheimer	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
and	NULL
Sturley	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

278	NULL
,	NULL
26765-26771	NULL
6	NULL
.	NULL

Lee	NULL
,	NULL
O.	NULL
,	NULL
Chang	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Lee	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Chang	NULL
,	NULL
T.	NULL
Y	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
J.	NULL
Lipid	NULL
Res	NULL
.	NULL

89	NULL
,	NULL
1722-1727	NULL
7	NULL
.	NULL

Chang	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Sakashita	NULL
,	NULL
N.	NULL
,	NULL
Ornvold	NULL
,	NULL
K.	NULL
,	NULL
Lee	NULL
,	NULL
O.	NULL
,	NULL
Chang	NULL
,	NULL
E.	NULL
T.	NULL
,	NULL
Dong	NULL
,	NULL
R.	NULL
,	NULL
Lin	NULL
,	NULL
S.	NULL
,	NULL
Lee	NULL
,	NULL
C.	NULL
Y.	NULL
,	NULL
Strom	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Kashyap	NULL
,	NULL
R.	NULL
,	NULL
Fung	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Farese	NULL
,	NULL
R.	NULL
V.	NULL
,	NULL
Jr.	NULL
,	NULL
Patoiseau	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Delhon	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Chang	NULL
,	NULL
T.	NULL
Y	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

275	NULL
,	NULL
28083-28092	NULL
8	NULL
.	NULL

Buhman	NULL
,	NULL
K.	NULL
K.	NULL
,	NULL
Accad	NULL
,	NULL
M.	NULL
,	NULL
Novak	NULL
,	NULL
S.	NULL
,	NULL
Choi	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
Wong	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Hamilton	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Turley	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Farese	NULL
,	NULL
R.	NULL
V.	NULL
,	NULL
Jr.	NULL
(	NULL
2000	NULL
)	NULL
Nat	NULL
.	NULL

Med	NULL
.	NULL

6	NULL
,	NULL
1841-1347	NULL
9	NULL
.	NULL

Lee	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
Willingham	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Davis	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Skinner	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
and	NULL
Rudel	NULL
,	NULL
L.	NULL
L.	NULL
(	NULL
2000	NULL
)	NULL
J.	NULL
Lipid	NULL
Res	NULL
.	NULL

41	NULL
,	NULL
1991-2001	NULL
10	NULL
.	NULL

Brown	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
and	NULL
Goldstein	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1983	NULL
)	NULL
Arnu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

52	NULL
,	NULL
228-261	NULL
11	NULL
.	NULL

Fielding	NULL
,	NULL
C.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
FASEB	NULL
J	NULL
.	NULL

6	NULL
,	NULL
8162-3168	NULL
12	NULL
.	NULL

Panousis	NULL
,	NULL
C.	NULL
G.	NULL
,	NULL
and	NULL
Zuckerman	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
2000	NULL
)	NULL
J.	NULL
Lipid	NULL
Res	NULL
.	NULL

41	NULL
,	NULL
75-83	NULL
13	NULL
.	NULL

Ross	NULL
,	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
362	NULL
,	NULL
801-809	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
20998	NULL
14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

28	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

Brown	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Ho	NULL
,	NULL
Y.	NULL
K.	NULL
,	NULL
and	NULL
Goldstein	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1980	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

255	NULL
,	NULL
9344-9352	NULL
Chang	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Lee	NULL
,	NULL
C.	NULL
Y.	NULL
,	NULL
Chang	NULL
,	NULL
E.	NULL
T.	NULL
,	NULL
Cruz	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Levesque	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
and	NULL
Chang	NULL
,	NULL
T.	NULL
Y	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

278	NULL
,	NULL
85182-85141	NULL
Panousis	NULL
,	NULL
C.	NULL
G.	NULL
,	NULL
and	NULL
Zuckerman	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
2000	NULL
)	NULL
Arterioscler	NULL
.	NULL

Thromb	NULL
.	NULL

Vasc	NULL
.	NULL

Biol	NULL
.	NULL

20	NULL
,	NULL
1565-1571	NULL
Banka	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Black	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Dyer	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
Curtiss	NULL
,	NULL
L.	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Lipid	NULL
Res	NULL
.	NULL

82	NULL
,	NULL
35-43	NULL
Alessio	NULL
,	NULL
M.	NULL
,	NULL
Monte	NULL
,	NULL
L	NULL
.	NULL

De	NULL
.	NULL

,	NULL
Scirea	NULL
,	NULL
A.	NULL
,	NULL
Gruarin	NULL
,	NULL
P.	NULL
,	NULL
Tandon	NULL
,	NULL
N.	NULL
N.	NULL
,	NULL
and	NULL
Sitia	NULL
,	NULL
R.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
1770-1775	NULL
Tontonoz	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
Nagy	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Alvalez	NULL
,	NULL
A.	NULL
,	NULL
Thomazy	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
and	NULL
Evans	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
Cell	NULL
98	NULL
,	NULL
241-252	NULL
Shiffman	NULL
,	NULL
D.	NULL
,	NULL
Mikita	NULL
,	NULL
T.	NULL
,	NULL
Tai	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
Wade	NULL
,	NULL
D.	NULL
P.	NULL
,	NULL
Porter	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Seilhamer	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Somogyi	NULL
,	NULL
R.	NULL
,	NULL
Liang	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Lawn	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
2000	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

275	NULL
,	NULL
37324-37382	NULL
Cheng	NULL
,	NULL
W.	NULL
,	NULL
Kvilekval	NULL
,	NULL
K.	NULL
V.	NULL
,	NULL
and	NULL
Abumrad	NULL
,	NULL
N.	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

269	NULL
,	NULL
E642-648	NULL
Cadigan	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
and	NULL
Chang	NULL
,	NULL
T.	NULL
Y	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J.	NULL
Lipid	NULL
Res	NULL
.	NULL

29	NULL
,	NULL
1683-1692	NULL
Chang	NULL
,	NULL
T.	NULL
Y.	NULL
,	NULL
and	NULL
Limanek	NULL
,	NULL
J.	NULL
S.	NULL
(	NULL
1980	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

255	NULL
,	NULL
7787-7795	NULL
Jiang	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Lu	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Chen	NULL
,	NULL
Y	NULL
.	NULL

Z.	NULL
,	NULL
and	NULL
Liu	NULL
,	NULL
X.	NULL
Y	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
Peptides	NULL
20	NULL
,	NULL
1385-1388	NULL
Bishop	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
and	NULL
Hajra	NULL
,	NULL
A.	NULL
K.	NULL
(	NULL
1980	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

106	NULL
,	NULL
344-350	NULL
Li	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
Li	NULL
,	NULL
X.	NULL
L.	NULL
,	NULL
Duan	NULL
,	NULL
Z.	NULL
J.	NULL
,	NULL
Lee	NULL
,	NULL
O.	NULL
,	NULL
Lin	NULL
,	NULL
S.	NULL
,	NULL
Ma	NULL
,	NULL
Z.	NULL
M.	NULL
,	NULL
Chang	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Yang	NULL
,	NULL
X.	NULL
Y.	NULL
,	NULL
Park	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Mohandas	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
Noll	NULL
,	NULL
W.	NULL
,	NULL
Chan	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Chang	NULL
,	NULL
T.	NULL
Y	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

274	NULL
,	NULL
11060-11071	NULL
Ho	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
Hunt	NULL
,	NULL
H.	NULL
D.	NULL
,	NULL
Horton	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Pullen	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
and	NULL
Pease	NULL
,	NULL
L.	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Gene	NULL
(	NULL
Amst	NULL
.	NULL
)	NULL

77	NULL
,	NULL
51-59	NULL
Vinkemeier	NULL
,	NULL
U.	NULL
,	NULL
Cohen	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Moarefi	NULL
,	NULL
L.	NULL
,	NULL
Chait	NULL
,	NULL
B.	NULL
T.	NULL
,	NULL
Kuriyan	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1996	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

15	NULL
,	NULL
5616-5626	NULL
Powell	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
Klaasse	NULL
Bos	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
van	NULL
Mourik	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

808	NULL
,	NULL
173-177	NULL
Mack	NULL
,	NULL
K.	NULL
D.	NULL
,	NULL
Wei	NULL
,	NULL
R.	NULL
,	NULL
Elbagarri	NULL
,	NULL
A.	NULL
,	NULL
Abbey	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
McGrath	NULL
,	NULL
M.	NULL
S.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
.	NULL

211	NULL
,	NULL
79-86	NULL
Liu	NULL
,	NULL
J.	NULL
,	NULL
Streiff	NULL
,	NULL
R.	NULL
,	NULL
Zhang	NULL
,	NULL
Y.	NULL
L.	NULL
,	NULL
Vestal	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Spence	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Briggs	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Lipid	NULL
Res	NULL
.	NULL

88	NULL
,	NULL
2035-2048	NULL
Sakamoto	NULL
,	NULL
S.	NULL
,	NULL
Nie	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1999	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

162	NULL
,	NULL
4881-4384	NULL
Andrews	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
and	NULL
Faller	NULL
,	NULL
D.	NULL
V.	NULL
(	NULL
1991	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19	NULL
,	NULL
2499	NULL
Oosta	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
Mathewson	NULL
,	NULL
N.	NULL
S.	NULL
,	NULL
and	NULL
Catravas	NULL
,	NULL
G.	NULL
N.	NULL
(	NULL
1978	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

89	NULL
,	NULL
31-34	NULL
Chang	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Chen	NULL
,	NULL
J.	NULL
,	NULL
Thomas	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Cheng	NULL
,	NULL
D.	NULL
,	NULL
Del	NULL
Priore	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
Newton	NULL
,	NULL
41	NULL
.	NULL

42	NULL
.	NULL

43.	NULL
.	NULL

Geng	NULL
,	NULL
Y.	NULL
J.	NULL
,	NULL
Holm	NULL
,	NULL
J.	NULL
,	NULL
Nygren	NULL
,	NULL
S.	NULL
,	NULL
Bruzelius	NULL
,	NULL
M.	NULL
,	NULL
Stemme	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Hansson	NULL
,	NULL
45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

Activation	NULL
of	NULL
ACAT-1	NULL
by	NULL
IFN-y	NULL
in	NULL
Foam	NULL
Cell	NULL
Formation	NULL
R.	NULL
S.	NULL
,	NULL
Pape	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
and	NULL
Chang	NULL
,	NULL
T.	NULL
Y	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
29532-29540	NULL
.	NULL

Schindler	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1995	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

64	NULL
,	NULL
621-651	NULL
.	NULL

Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
,	NULL
Kerr	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
and	NULL
Stark	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
264	NULL
,	NULL
1415-1421	NULL
.	NULL

Aguet	NULL
,	NULL
M.	NULL
,	NULL
Dembic	NULL
,	NULL
Z.	NULL
,	NULL
and	NULL
Merlin	NULL
,	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
55	NULL
,	NULL
273-280	NULL
.	NULL

Schindler	NULL
,	NULL
C.	NULL
,	NULL
Shuai	NULL
,	NULL
K.	NULL
,	NULL
Prezioso	NULL
,	NULL
V.	NULL
R.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
257	NULL
,	NULL
809-813	NULL
.	NULL

Walter	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Look	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Tidwell	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Roswit	NULL
,	NULL
W.	NULL
T.	NULL
,	NULL
and	NULL
Holtzman	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
28582-28589	NULL
Wang	NULL
,	NULL
H.	NULL
,	NULL
Germain	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Benfield	NULL
,	NULL
P.	NULL
P.	NULL
,	NULL
and	NULL
Gillies	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Arterioscler	NULL
.	NULL

Thromb	NULL
.	NULL

Vasc	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
809-814	NULL
Miyazaki	NULL
,	NULL
A.	NULL
,	NULL
Sakashita	NULL
,	NULL
N.	NULL
,	NULL
Lee	NULL
,	NULL
O.	NULL
,	NULL
Takahashi	NULL
,	NULL
K.	NULL
,	NULL
Horiuchi	NULL
,	NULL
S.	NULL
,	NULL
Hakamata	NULL
,	NULL
H.	NULL
,	NULL
Morganelli	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
Chang	NULL
,	NULL
C.	NULL
C.	NULL
Y.	NULL
,	NULL
and	NULL
Chang	NULL
,	NULL
T.	NULL
Y	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Arterioscler	NULL
.	NULL

Thromb	NULL
.	NULL

Vase	NULL
.	NULL

Bio	NULL
.	NULL

18	NULL
,	NULL
1568-1574	NULL
Hansson	NULL
,	NULL
G.	NULL
K.	NULL
,	NULL
Holm	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Jonasson	NULL
,	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

185	NULL
,	NULL
169-175	NULL
G.	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
Arterioscler	NULL
.	NULL

Thromb	NULL
.	NULL

Vasc	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
1995-2002	NULL
Li	NULL
,	NULL
H.	NULL
,	NULL
Cybulsky	NULL
,	NULL
M.	NULL
I.	NULL
,	NULL
Gimbrone	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
Libby	NULL
,	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
Arterioscler	NULL
Thromb	NULL
.	NULL

18	NULL
,	NULL
197-204	NULL
Whitman	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Argmann	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Sawyez	NULL
,	NULL
C.	NULL
G.	NULL
,	NULL
Miller	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Hegele	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Huff	NULL
,	NULL
M.	NULL
W.	NULL
(	NULL
1999	NULL
)	NULL
J.	NULL
Lipid	NULL
Res	NULL
.	NULL

40	NULL
,	NULL
1017-1028	NULL
Jonasson	NULL
,	NULL
L.	NULL
,	NULL
Holm	NULL
,	NULL
J.	NULL
,	NULL
Skalli	NULL
,	NULL
O.	NULL
,	NULL
Gabbiani	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Hansson	NULL
,	NULL
G.	NULL
K.	NULL
(	NULL
1985	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

76	NULL
,	NULL
125-1831	NULL
Li	NULL
,	NULL
H.	NULL
,	NULL
Freeman	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
and	NULL
Libby	NULL
,	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

95	NULL
,	NULL
122-133	NULL
Christen	NULL
,	NULL
S.	NULL
,	NULL
Thomas	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Garner	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Stocker	NULL
,	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

93	NULL
,	NULL
2149-2158	NULL
Geng	NULL
,	NULL
Y.	NULL
J.	NULL
,	NULL
and	NULL
Hansson	NULL
,	NULL
G.	NULL
K.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

89	NULL
,	NULL
1822-1330	NULL
Gupta	NULL
,	NULL
S.	NULL
,	NULL
Pablo	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Jiang	NULL
,	NULL
X.	NULL
C.	NULL
,	NULL
Wang	NULL
,	NULL
N.	NULL
,	NULL
Tall	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
and	NULL
Schindler	NULL
,	NULL
C.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

99	NULL
,	NULL
2752-2761	NULL
Tellides	NULL
,	NULL
G.	NULL
,	NULL
Tereb	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Kirkiles-Smith	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
Kim	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
Wilson	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Schechner	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Lorber	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
Pober	NULL
,	NULL
J.	NULL
S.	NULL
(	NULL
2000	NULL
)	NULL
Nature	NULL
408	NULL
,	NULL
207-211	NULL
Mangelsdorf	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Umesono	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Evans	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
in	NULL
The	NULL
Retinoids	NULL
:	NULL
Biology	NULL
,	NULL
Chemistry	NULL
and	NULL
Medicine	NULL
(	NULL
Sporn	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Roberts	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Goodman	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
eds	NULL
)	NULL
2nd	NULL
Ed	NULL
.	NULL

,	NULL
pp	NULL
.	NULL

819-8349	NULL
,	NULL
Raven	NULL
Press	NULL
,	NULL
Ltd.	NULL
,	NULL
New	NULL
York	NULL
Gianni	NULL
,	NULL
M.	NULL
,	NULL
Terao	NULL
,	NULL
M.	NULL
,	NULL
Fortino	NULL
,	NULL
I.	NULL
,	NULL
LiCalzi	NULL
,	NULL
M.	NULL
,	NULL
Viggiano	NULL
,	NULL
V.	NULL
,	NULL
Barbui	NULL
,	NULL
T.	NULL
,	NULL
Rambaldi	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Garattini	NULL
,	NULL
E.	NULL
(	NULL
1997	NULL
)	NULL
Blood	NULL
89	NULL
,	NULL
1001-1012	NULL
Matikainen	NULL
,	NULL
S.	NULL
,	NULL
Lehtonen	NULL
,	NULL
A.	NULL
,	NULL
Sareneva	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Julkunen	NULL
,	NULL
I	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Leuk	NULL
.	NULL

&	NULL
Lymphoma	NULL
80	NULL
,	NULL
63-71	NULL
Matikainen	NULL
,	NULL
S.	NULL
,	NULL
Ronni	NULL
,	NULL
T.	NULL
,	NULL
Lehtonen	NULL
,	NULL
A.	NULL
,	NULL
Sareneva	NULL
,	NULL
T.	NULL
,	NULL
Melen	NULL
,	NULL
K.	NULL
,	NULL
Nordling	NULL
,	NULL
S.	NULL
,	NULL
Levy	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
and	NULL
Julkunen	NULL
,	NULL
I	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

8	NULL
,	NULL
687-698	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Synergistic	NULL
Transcriptional	NULL
Activation	NULL
of	NULL
HumanAcyl-coenzyme	NULL
A	NULL
:	NULL
Cholesterol	NULL
Acyltransterase-1	NULL
Gene	NULL
by	NULL
Interferon-y	NULL
and	NULL
All-trans-Retinoic	NULL
Acid	NULL
THP	NULL
-1	NULL
Cells	NULL
Jin-Bo	NULL
Yang	NULL
,	NULL
Zhi-Jun	NULL
Duan	NULL
,	NULL
Wei	NULL
Yao	NULL
,	NULL
Oneil	NULL
Lee	NULL
,	NULL
Li	NULL
Yang	NULL
,	NULL
Xin-Y	NULL
ing	NULL
Yang	NULL
,	NULL
Xia	NULL
Sun	NULL
,	NULL
Catherine	NULL
C.	NULL
Y.	NULL
Chang	NULL
,	NULL
Ta-Yuan	NULL
Chang	NULL
and	NULL
Bo-Liang	NULL
Li	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

2001	NULL
,	NULL
276:20989-20998.	NULL
doi	NULL
:	NULL
10.1074/jbc.MO1	NULL
1488200	NULL
originally	NULL
published	NULL
online	NULL
February	NULL
28	NULL
,	NULL
2001	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
doi	NULL
:	NULL
10.1074/jbe	NULL
.	NULL

M01	NULL
1488200	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
55	NULL
references	NULL
,	NULL
30	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL

